{"SLR NAME":"Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies","References":[{"title1":"Intensive care for seriously ill patients affected by novel coronavirus sars - CoV – 2: Experience of the Crema Hospital, Italy","References":[{"title2":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","References":[{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia"},{"title3":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"COVID-19-related myocarditis in a 21-year-old female patient"},{"title3":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin"},{"title3":"Immune-mediated mechanism in coronavirus fulminant myocarditis"},{"title3":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3"},{"title3":"Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation"},{"title3":"Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes"},{"title3":"Platelets support a protective immune response to LCMV by preventing splenic necrosis"},{"title3":"Platelets in pulmonary immune responses and inflammatory lung diseases"},{"title3":"In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)"},{"title3":"Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009"},{"title3":"Understanding platelets in infectious and allergic lung diseases"},{"title3":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)"}]},{"title2":"COVID - 19 coagulopathy: an evolving story","References":[]},{"title2":"Coagulation abnormalities and thrombosis in patients with COVID - 19","References":[{"title3":"Covid-19 in critically ill patients in the Seattle region:case series"},{"title3":"How I treat disseminated intravascular coagulation"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Response of Chinese anesthesiologists to the COVID-19 outbreak","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"Coronavirus disease (COVID-19) outbreak."},{"title3":"Novel Coronavirus (COVID-19) Situation."},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003."},{"title3":"From SARS-CoV to 2019-nCoV outbreak: Similarities in the early epidemics and prediction of future trends."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention."},{"title3":"Vital surveillances:the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020."},{"title3":"Perioperative care providers' considerations in managing patients with COVID-19 infections."},{"title3":"China confirms human-to-human transmission of 2019-nCoV, infection ofmedical staff."},{"title3":"The first Fang Cang hospital is closed"},{"title3":"Coronavirus Fight: A race against death! Intubation team in Wuhan doutmost to save patients."},{"title3":"A letter to the heads of anesthesia departments in China."},{"title3":"Mental health care platform for anesthesia medical staff in Hubei."},{"title3":"Anesthesia experts online Q&amp;A forum."},{"title3":"Anesthesia and Nursing Standard Operation Protocol in Operating Rooms for Patients with Suspected and Confirmed COVID-19."},{"title3":"Recommendations for tracheal intubation in critically ill COVID-19 patients (Version 1.0)."},{"title3":"Pediatric anesthesia-related specifications during the COVID-19 Epidemic."},{"title3":"The New Youth Anesthesia Forum online streaming."},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned?"}]},{"title2":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection - a review of immune changes in patients with viral pneumonia","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway"},{"title3":"[Clinical features and therapy of 106 cases of severe acute respiratory syndrome]"},{"title3":"[The alterations of T cell subsets of severe acute respiratory syndrome during acute phase]"},{"title3":"[Dynamic changes of T lymphocyte subsets in the long-term follow-up of severe acute respiratory syndrome patients]"},{"title3":"[Variation in the titer of the specific IgG antibody in patients with SARS]"},{"title3":"Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients"},{"title3":"SARS: Systematic review of treatment effects"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract"},{"title3":"Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses"},{"title3":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection"},{"title3":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza"},{"title3":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans"},{"title3":"[Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza]"},{"title3":"Influenza virus infection but not H1N1 influenza virus immunization is associated with changes in peripheral blood NK cell subset levels"},{"title3":"2010 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Pathogenesis and transmission of Swine-Origin 2009 A(H1N1) influenza virus in Ferrets"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Multiple organ infection and the pathogenesis of SARS[J]"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Quantitative mRNA expression pro$ling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"}]},{"title2":"Trial of Lopinavir-Ritonavir in adults hospitalized with severe covid-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds."},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome."},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen."},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) home page ()."},{"title3":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection."},{"title3":"Coronavirus disease (COVID-2019) R&amp;D. Geneva: World Health Organization ()."},{"title3":"National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London: Royal College of Physicians, 2017 ()."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data."},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09."},{"title3":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus."}]},{"title2":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19","References":[{"title3":"World Health Organization. Novel coronavirus (2019-nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance. Accessed 14 Feb 2020."},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for healthcare professionals. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html. Accessed 14 Feb 2020."},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review"},{"title3":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro"},{"title3":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19"},{"title3":"Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732-9."},{"title3":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology"},{"title3":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review"},{"title3":"Propensity score"},{"title3":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies"},{"title3":"Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders"},{"title3":"Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for drug interactions on QTc in exploratory COVID-19 treatment. Circulation. 2020;141(24):e906-7."},{"title3":"Kapoor A, Pandurangi U, Arora V, et al. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: a scientific statement from the Indian Heart Rhythm Society. Indian Pacing Electrophysiol J. 2020;20(3):117-120."},{"title3":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial"},{"title3":"Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness"},{"title3":"Guastalegname M, Vallone A. Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment? Clin Infect Dis. 2020;71(15):888-9."},{"title3":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin"},{"title3":"Wu CI, Postema PG, Arbelo E, et al. SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. Heart Rhythm. 202017(9):1456-62."},{"title3":"QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine"},{"title3":"Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation"}]},{"title2":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","References":[]},{"title2":"Effective Treatment of Severe COVID-19 Patients with Tocilizumab","References":[{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients"},{"title3":"Clinical experience of IL-6 blockade in rheumatic diseases-Implications on IL-6 biology and disease pathogenesis"},{"title3":"Interleukin-6 and its receptors: A highly regulated and dynamic system"},{"title3":"Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling"},{"title3":"Tocilizumab:a novel therapy for non-organ-specific autoimmune diseases"},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase III trial"},{"title3":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): A randomised, double-blind, controlled phase 4 trial"},{"title3":"Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with mesothelin-targeted CAR-T cells"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Trigger fisici e biologici del danno polmonare indotto dal ventilatore (VILI) e sua prevenzione","References":[]},{"title2":"COVID-19 pneumonia: different respiratory treatment for different phenotypes?","References":[]}]},{"title1":"Very severe COVID-19 in the critically ill in Tunisia","References":[{"title2":"Covid-19 in Critically Ill Patients in the Seattle Region-Case Series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Premier cas confirme de COVID-19 importe en Tunisie First case of imported and confirmed COVID-19 in Tunisia","References":[]},{"title2":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","References":[]},{"title2":"A simplified acute physiology score for ICU patients","References":[]},{"title2":"A Tunisian version of the confusion assessment method for the intensive care unit (CAM-ICU): translation and validation","References":[{"title3":"Delirium in the ICU: an overview"},{"title3":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit"},{"title3":"Incidence, risk factors and consequences of ICU delirium"},{"title3":"Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study"},{"title3":"Clinical practice guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit"},{"title3":"Prevention, Recognition, and Management of Delirium in the Intensive Care Unit"},{"title3":"Epidemiology and risk factors for delirium across hospital settings"},{"title3":"Barriers to delirium assessment in the intensive care unit: a literature review"},{"title3":"Delirium scales: a review of current evidence"},{"title3":"Validation of the Greek version of confusion assessment method for the intensive care unit (CAM-ICU)"},{"title3":"Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU)"},{"title3":"Intensive care delirium screening checklist: evaluation of a new screening tool"},{"title3":"Delirium and sedation recognition using validated instruments: reliability of bedside intensive care unit nursing assessments from 2007 to 2010"},{"title3":"Aljuaid MH, Deeb AM, Dbsawy M, Alsayegh D, Alotaibi M, Arabi YM. Psychometric properties of the Arabic version of the confusion assessment method for the intensive care unit (CAM-ICU). BMC Psychiatry. 2018;18. 10.1186/s12888-018-1676-0."},{"title3":"The validity and reliability of the Arabic version of the confusion assessment method for the intensive care unit (CAM-ICU): a prospective cohort study"},{"title3":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)"},{"title3":"Sample size estimation in epidemiologic studies"},{"title3":"Delirium in the intensive care unit: incidence, risk factors, and impact on outcome"},{"title3":"The Richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients"},{"title3":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation"},{"title3":"A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study"},{"title3":"The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer"},{"title3":"The measurement of observer agreement for categorical data"},{"title3":"Instrument translation process: a methods review"},{"title3":"The experience of delirium care and clinical feasibility of the CAM-ICU in a Korean ICU"},{"title3":"Routine use of the confusion assessment method for the intensive care unit: a multicenter study"},{"title3":"Confusion assessment method for the intensive care unit (CAM-ICU): translation, retranslation and validation into Swedish intensive care settings"},{"title3":"Delirium among critically ill adults: Evaluation of the psychometric properties of the Italian 'Confusion Assessment Method for the Intensive Care Unit'"},{"title3":"Reliability and validity assessment of the Japanese version of the confusion assessment method for the intensive care unit (CAM-ICU)"},{"title3":"Translation and validation of the Korean confusion assessment method for the intensive care unit"},{"title3":"Delirium assessment tools for use in critically ill adults: a psychometric analysis and systematic review"},{"title3":"A nationwide study on delirium in psychiatric patients from 1995 to 2011"},{"title3":"Delirium epidemiology in critical care (DECCA): an international study"},{"title3":"The validity and reliability of the Portuguese versions of three tools used to diagnose delirium in critically ill patients"},{"title3":"Delirium assessment using confusion assessment method for the intensive care unit in Chinese critically ill patients"},{"title3":"Poststroke delirium incidence and outcomes: validation of the confusion assessment method for the intensive care unit (CAM-ICU)"},{"title3":"Validity and reliability of the Thai version of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)"},{"title3":"Comparison of delirium assessment tools in a mixed intensive care unit*"},{"title3":"Spanish version of the CAM-ICU (confusion assessment method for the intensive care unit). Pilot study of validation"},{"title3":"Validity and reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients"},{"title3":"Validation of a German version of the confusion assessment method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia"},{"title3":"Disruption of circadian rhythms and delirium, sleep impairment and Sepsis in critically ill patients. Potential therapeutic implications for increased light-dark contrast and melatonin therapy in an ICU environment"},{"title3":"Assessment of delirium in the intensive care unit: nursing practices and perceptions"},{"title3":"Implementation, reliability testing, and compliance monitoring of the confusion assessment method for the intensive care unit in trauma patients"}]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"The Richmond Agitation-Sedation Scale: Validity and Reliability in Adult Intensive Care Unit Patients","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Profil clinique, biologique et radiologique des patients Algeriens hospitalises pour COVID-19: donnees preliminaires","References":[{"title3":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence"},{"title3":"Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention"},{"title3":"COVID-19: clinical, biological and radiological characteristics in adults, infants and pregnant women. An up-to-date review at the heart of the pandemic"},{"title3":"Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients"},{"title3":"Interpreting diagnostic tests for SARS-CoV-2"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis"},{"title3":"Novel Coronavirus infection (COVID-19) in humans: A scoping review and meta-analysis"},{"title3":"Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series"},{"title3":"Clinical characteristics of Coronavirus disease 2019 in China"},{"title3":"The Clinical and chest CT features associated with severe and critical COVID-19 pneumonia"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Olfactory neuropathy in severe acute respiratory syndrome: report of A case"},{"title3":"Chest CT findings in 2019 Nnovel Coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Radiological findings in patients with COVID-19"},{"title3":"Covid-19 coronavirus pandemic"},{"title3":"Association between hypoxemia and mortality in patients with COVID-19"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Chest CT findings in patients with Coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial"},{"title3":"Ethnic and sex differences in the total and differential white cell count and platelet count"},{"title3":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis"},{"title3":"Agreement between erythrocyte sedimentation rate and C-reactive protein in hospital practice"},{"title3":"Normal erythrocyte sedimentation rate and age"},{"title3":"Simplified determinations of the &quot;true&quot; creatinine concentration in serum and urine"},{"title3":"Nitrogen metabolites and renal function"},{"title3":"Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European committee for clinical laboratory standards (ECCLS)"},{"title3":"Improvement of result coherence in clinical enzymology: multicenter study of gamma-glutamyltransferase, alkaline phosphatase and amylase activities"},{"title3":"Differences in serum potassium concentrations in normal men in different geographic locations"},{"title3":"Hyponatremia and hypernatremia"},{"title3":"Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis"},{"title3":"National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes"},{"title3":"Biological variance of total lactate dehydrogenase and its isoenzymes in human serum"},{"title3":"The creatine kinase reference interval. An assessment of intra- and inter-individual variation"},{"title3":"The crazy-paving sign"},{"title3":"COVID-19: pathogenesis of a multi-faceted disease"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Smoking is associated with COVID-19 progression: a meta-analysis"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The incubation period of Coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Gastrointestinal and liver manifestations of COVID-19"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China"},{"title3":"Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China"},{"title3":"Acute kidney injury associated with coronavirus disease 2019 in Urban New Orleans"},{"title3":"The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis"},{"title3":"Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?"},{"title3":"COVID-19: Multiple diseases simulating extreme high-altitude exposure? Oxygen transport physiology and scarce need of ventilators; andean condor s-eye-view"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China"},{"title3":"Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China"}]},{"title2":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","References":[]},{"title2":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients","References":[]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","References":[{"title3":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. The American review of respiratory disease"},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome"},{"title3":"Lung inhomogeneity in patients with acute respiratory distress syndrome"},{"title3":"Respiratory drive in critically ill patients. Pathophysiology and clinical implications"},{"title3":"Positive pressure respiration and its application to the treatment of acute pulmonary edema"},{"title3":"Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study"},{"title3":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure"},{"title3":"Vertical gradient of regional lung inflation in adult respiratory distress syndrome"},{"title3":"Reclassifying acute respiratory distress syndrome"},{"title3":"Targeting transpulmonary pressure to prevent ventilator-induced lung injury"},{"title3":"A comparison of oesophageal and central venous pressures in the measurement of transpulmonary pressure change"}]},{"title2":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia","References":[]},{"title2":"Vademecum for the treatment of people with COVID-19","References":[]},{"title2":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","References":[{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-An update on the status"},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review"},{"title3":"Hydroxychloroquine: From malaria to autoimmunity"},{"title3":"New insights on the antiviral effects of chloroquine against coronavirus: What to expect for COVID-19??"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro"},{"title3":"RoB 2: A revised tool for assessing risk of bias in randomised trials?"},{"title3":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions?"},{"title3":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments"},{"title3":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses"},{"title3":"Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: A quasi-randomized comparative study"},{"title3":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial?"},{"title3":"[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]"},{"title3":"Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial. 2020"},{"title3":"Treating COVID-19 with Chloroquine"},{"title3":"Effect of hydroxychloroquine in hospitalized patients with Covid-19"},{"title3":"Repurposed antiviral drugs for Covid-19-Interim WHO Solidarity Trial Results"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial?"},{"title3":"Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin"},{"title3":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State"},{"title3":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19"},{"title3":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19"},{"title3":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: Observational comparative study using routine care data"},{"title3":"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19"},{"title3":"Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome"},{"title3":"Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19"},{"title3":"Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study"},{"title3":"Outcomes of hydroxychloroquine treatment among hospitalized COVID-19 patients in the United States- Real-world evidence from a federated electronic medical record network"},{"title3":"Early hydroxychloroquine is associated with an increase of survival in COVID-19 patients: An observational study. Preprints 2020, 2020050057"},{"title3":"Retraction:Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Negative nasopharyngeal SARS-CoV-2 PCR conversion in response to different therapeutic interventions"},{"title3":"Association of polymorphisms of cytochrome P450 2D6 with blood hydroxychloroquine levels in patients with systemic lupus erythematosus"},{"title3":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study?"},{"title3":"Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment"},{"title3":"Rapid onset of retinal toxicity from high-dose hydroxychloroquine given for cancer therapy"},{"title3":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision)"}]},{"title2":"Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"},{"title3":"First newborn baby to receive experimental therapies survives Ebola virus disease"},{"title3":"First 12 patients with coronavirus disease 2019 (COVID-19) in the United States."},{"title3":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Clinical pharmacokinetics of slow-acting antirheumatic drugs"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial"},{"title3":"Of chloroquine and COVID-19"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"The diagnosis and treatment guide of COVID-19 pneumonia caused by new coronavirus infection 7th Edition, published March 3rd, 2020."},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR"},{"title3":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children"},{"title3":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus"},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome"},{"title3":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells"},{"title3":"Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Convalescent plasma as a potential therapy for COVID-19"},{"title3":"Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes"},{"title3":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Broad spectrum antiviral agent niclosamide and its therapeutic potential"},{"title3":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19"},{"title3":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial"}]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72? 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"COVID-19 and its implications for thrombosis and anticoagulation","References":[]},{"title2":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Coronavirus disease 2019 (COVID-19) Situation Report - 69 [Accessed: Mar 29,2020]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200329-sitrep-69-covid-19.pdf."},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"COVID-19 complicated with DIC: 2 cases report and literatures review"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Procoagulant activity during viral infections"},{"title3":"Review: Infectious Diseases and Coagulation Disorders"},{"title3":"Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression"},{"title3":"The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases"},{"title3":"Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets"},{"title3":"The SARS epidemic in Hong Kong: what lessons have we learned?"},{"title3":"Update: Outbreak of severe acute respiratory syndrome--worldwide, 2003"},{"title3":"WHO | SARS (Severe Acute Respiratory Syndrome) [Internet]. WHO. World Health Organization; [Accessed: Mar 27, 2020]. Available from: https://www.who.int/ith/diseases/sars/en/."},{"title3":"Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome"},{"title3":"Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)"},{"title3":"Pathological study on severe acute respiratory syndrome"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Analysis of Deaths During the Severe Acute Respiratory Syndrome (SARS) Epidemic in Singapore: Challenges in Determining a SARS Diagnosis"},{"title3":"Ye-nan W. Severe Acute Respiratory Syndrome and Venous Thromboembolism in Multiple Organs"},{"title3":"The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation"},{"title3":"Thrombopoietin levels increased in patients with severe acute respiratory syndrome"},{"title3":"A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong"},{"title3":"Predictive model of diagnosing probable cases of severe acute respiratory syndrome in febrile patients with exposure risk"},{"title3":"Osteonecrosis in patients after severe acute respiratory syndrome (SARS): possible role of anticardiolipin antibodies"},{"title3":"Severe acute respiratory syndrome and lupus anticoagulants in children"},{"title3":"A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection"},{"title3":"Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration"},{"title3":"Thromboxane and the thromboxane receptor in cardiovascular disease"},{"title3":"Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis"},{"title3":"Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229E"},{"title3":"Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels"},{"title3":"Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis"},{"title3":"The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha"},{"title3":"Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene"},{"title3":"Molecular pathology of emerging coronavirus infections"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Middle East Respiratory Syndrome Virus Pathogenesis"},{"title3":"Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description"},{"title3":"Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature"},{"title3":"Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4"},{"title3":"Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","References":[]},{"title2":"Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis","References":[]},{"title2":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic","References":[{"title3":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic"},{"title3":"Early sedation with dexmedetomidine in critically ill patients"},{"title3":"Garber PM, Droege CA, Carter KE, Harger NJ, Mueller EW. Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy. 2019;39(3):288-96. 10.1002/phar.2223."},{"title3":"Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020. 10.1016/j.ajem.2020.04.048."},{"title3":"Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations"},{"title3":"Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial"},{"title3":"Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial"},{"title3":"Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study"},{"title3":"Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial"}]},{"title2":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","References":[{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy"},{"title3":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients"},{"title3":"Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom"},{"title3":"Where do we stand with antithrombotic prophylaxis in patients with COVID-19?"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Thromboinflammation and the hypercoagulability of COVID-19"},{"title3":"Pulmonary embolism"}]},{"title2":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","References":[]},{"title2":"Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography","References":[{"title3":"Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing [published online ahead of print, 2020 Feb 12]"},{"title3":"ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection"},{"title3":"China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia [published online ahead of print, 2020 Feb 19]"},{"title3":"Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients"},{"title3":"Findings of acute pulmonary embolism in COVID-19 patients"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"}]}]},{"title1":"Effect of Early vs. Delayed or No Intubation on Clinical Outcomes of Patients With COVID-19: An Observational Study","References":[{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical features of covid-19","References":[]},{"title2":"Clinical characteristics of covid-19 in New York city","References":[{"title3":"COVID-19 Map"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Aki in hospitalized patients with and without COVID-19: a comparison study"},{"title3":"Aki in hospitalized patients with COVID-19"},{"title3":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"Thrombosis in hospitalized patients with COVID-19 in a new York City health system"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy"},{"title3":"States reporting cases of COVID-19 to CDC"},{"title3":"Defining the Epidemiology of Covid-19 - Studies Needed"},{"title3":"R: a language and environment for statistical computing. R found STAT comput Vienna, Austria; R foundation for statistical computing"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"SARS-CoV-2 infection among travelers returning from Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 in critically Ill patients in the seattle region - case series"},{"title3":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients"},{"title3":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis"},{"title3":"Clinical characteristics of Covid-19 in New York City"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"}]},{"title2":"COVID-19 pneumonia: ARDS or not?","References":[]},{"title2":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review","References":[{"title3":"Lessons learned: protection of healthcare workers from infectious disease risks."},{"title3":"Severe acute respiratory syndrome and coronavirus."},{"title3":"A review of the risks and disease transmission associated with aerosol generating medical procedures."},{"title3":"Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature."},{"title3":"British Thoracic Society Hospital Management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges - updated. London: British Thoracic Society."},{"title3":"Epidemic and pandemic-prone acute respiratory diseases - Infection prevention and control in health care: Aide memoire. Geneva: WHO."},{"title3":"Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Supplement I: infection control in healthcare, home, and community settings. Atlanta (GA): CDC."},{"title3":"Occupationally acquired infections in health care workers. Part I. Ann Intern Med 125:826-834."},{"title3":"Control of influenza in healthcare settings: early lessons from the 2009 pandemic."},{"title3":"Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines."},{"title3":"Infection control measures for operative procedures in Severe Acute Respiratory Syndrome-related Patients."},{"title3":"Chapter 8. Medical procedures. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster."},{"title3":"ASID (HICSIG) position statement: infection control guidelines for patients with influenza-like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities."},{"title3":"2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings."},{"title3":"Prevention and control of healthcare-associated infections in Massachusetts. Part 1: final recommendations of the Expert Panel. Boston: Massachusetts Department of Public Health."},{"title3":"Alberta SARS response: infection prevention and control guidelines for acute febrile respiratory illness and SARS in acute care settings. Edmonton: Alberta Health and Wellness, Disease Control and Prevention."},{"title3":"Infection prevention and control. Clinical Best practice guidelines. Toronto: College of Respiratory Therapists of Ontario."},{"title3":"Cochrane handbook for systematic reviews of interventions. Version 5.0.1. Oxford (UK): Cochrane Collaboration."},{"title3":"GRADE. [place unknown]: The GRADE Working Group."},{"title3":"Which preventive measures might protect health care workers from SARS? BMC Public Health 9:81."},{"title3":"Investigation of the influencing factors on severe acute respiratory syndrome among health care workers."},{"title3":"A case-control study on the risk factors of severe acute respiratory syndromes among health care workers."},{"title3":"Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore."},{"title3":"Risk factors for SARS infection among hospital healthcare workers in Beijing: A case control study."},{"title3":"Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS ONE 5:e10717."},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 169:1198-1202."},{"title3":"SARS among critical care nurses, Toronto."},{"title3":"Cluster of SARS among medical students exposed to single patient, Hong Kong."},{"title3":"Illness in intensive care staff after brief exposure to severe acute respiratory syndrome."},{"title3":"Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37:1148-1157."}]},{"title2":"Caution about early intubation and mechanical ventilation in COVID-19","References":[{"title3":"Management of COVID-19 respiratory distress"},{"title3":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure"},{"title3":"Covid-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study"},{"title3":"Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume"},{"title3":"Basing respiratory management of COVID-19 on physiological principles"},{"title3":"Monitoring of the control of ventilation"},{"title3":"Ventilatory failure, ventilator support and ventilator weaning"}]},{"title2":"P-SILI is not justification for intubation of COVID-19 patients","References":[{"title3":"Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients"},{"title3":"A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients"},{"title3":"Ventilatory-associated barotrauma in COVID-19 patients: a multicenter observational case control study (COVI-MIX Study)"},{"title3":"Cammarota G, Simonte R, Longhini F, Spadaro S, Vetrugno L, De Robertis E. Advanced point-of-care bedside monitoring for acute respiratory failure. Anesthesiology. Published online 2023."},{"title3":"Venovenous extracorporeal membrane oxygenation in awake non-intubated patients with COVID-19 ARDS at high risk for barotrauma"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Potential association between COVID-19 mortality and health-care resource availability","References":[{"title3":"Distribution of new coronavirus pneumonia"},{"title3":"Examining the multi-scalar unevenness of high-quality healthcare resources distribution in China"},{"title3":"Africa prepares for coronavirus"}]},{"title2":"Why COVID-19 silent hypoxemia is baffling to physicians","References":[{"title3":"Some doctors pull back on using ventilators to treat Covid-19"},{"title3":"The mystery of the pandemic's 'happy hypoxia'"},{"title3":"The infection that's silently killing coronavirus patients"},{"title3":"Effect of endotoxin on ventilation and breath variability: role of cyclooxygenase pathway"},{"title3":"Basing respiratory management of COVID-19 on physiological principles"},{"title3":"Dyspnea: pathophysiologic basis, clinical presentation, and management"},{"title3":"Addressing respiratory discomfort in the ventilated patient"},{"title3":"Stimulus-response characteristics of CO2-induced air hunger in normal subjects"},{"title3":"Ventilatory failure, ventilator support, and ventilator weaning"},{"title3":"Monitoring of the control of ventilation"},{"title3":"Hypoxic ventilatory drive in normal man"},{"title3":"Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans"},{"title3":"The effect of hypoxia on the ventilatory response to carbon dioxide in man"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men"},{"title3":"Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hypercapnia"},{"title3":"Ventilatory and heart rate responses to hypoxia and hypercapnia in patients with diabetes mellitus"},{"title3":"Abnormal ventilatory responses to hypoxia in Type 2 diabetes"},{"title3":"Diminished perception of inspiratory-resistive loads in insulin-dependent diabetics"},{"title3":"Variability of resting respiratory drive and timing in healthy subjects"},{"title3":"Diuretic effect of acute hypoxia in humans: relationship to hypoxic ventilatory responsiveness and renal hormones"},{"title3":"Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema"},{"title3":"The relationship of hypercapnic ventilatory responses to age, gender and athleticism"},{"title3":"Effect of isocapnic hypoxia on variational activity of breathing"},{"title3":"Effects of acute, profound hypoxia on healthy humans: implications for safety of tests evaluating pulse oximetry or tissue oximetry performance"},{"title3":"Pulse oximetry"},{"title3":"Acute hypoxia in a simulated high-altitude airdrop scenario due to oxygen system failure"},{"title3":"Arterial oxygen saturation, pulse oximetry, and cerebral and tissue oximetry in hypobaric hypoxia"},{"title3":"Accuracy of pulse oximetry in the intensive care unit"},{"title3":"Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator-dependent patients"},{"title3":"Digital computer subroutine for the conversion of oxygen tension into saturation"},{"title3":"Expressions of angiotensin and cytokine receptors in the paracrine signaling of the carotid body in hypoxia and sleep apnea"},{"title3":"Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study"},{"title3":"Pathophysiology of dyspnoea in acute pulmonary embolism: a cross-sectional evaluation"},{"title3":"Arterial oxygen tension in relation to age in healthy subjects"},{"title3":"Reference values for gas exchange during exercise in healthy nonsmoking and smoking men"},{"title3":"Pathophysiology and clinical effects of chronic hypoxia"},{"title3":"Variability of inspired oxygen concentration with nasal cannulas"},{"title3":"Simple, accurate equations for human blood O2 dissociation computations"},{"title3":"Why physiology is critical to the practice of medicine: a 40-year personal perspective"}]},{"title2":"Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit","References":[{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine"},{"title3":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study"},{"title3":"Systemic inflammatory response syndrome criteria in defining severe sepsis"},{"title3":"Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"qSOFA does not replace SIRS in the definition of sepsis"},{"title3":"Sepsis-3: What is the meaning of a definition?"},{"title3":"New sepsis criteria: a change we should not make"},{"title3":"Opening the debate on the new sepsis definition. Change is not necessarily progress: revision of the sepsis definition should be based on new scientific insights"},{"title3":"The misapplication of severity-of-illness scores toward clinical decision making"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-8."},{"title3":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome"},{"title3":"The meaning and use of the area under a receiver operating characteristic (ROC) curve"},{"title3":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference"},{"title3":"Churpek MM, Snyder A, Han X, Sokol S, Pettit N, Howell MD, Edelson DP. qSOFA, SIRS, and early warning scores for detecting clinical deterioration in infected patients outside the ICU. Am J Respir Crit Care Med. 2016. [Epub ahead of print]"},{"title3":"Predictive performance of quick Sepsis-related Organ Failure Assessment for mortality and ICU admission in patients with infection at the ED"},{"title3":"Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department"},{"title3":"Quick sequential organ failure assessment: big databases vs. intelligent doctors"},{"title3":"Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit"},{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"}]},{"title2":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"PEEP levels in COVID-19 pneumonia","References":[{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill"},{"title3":"Jamil S, Mark N, Carlos G, Dela Cruz C, Gross J, Pasnick S. Diagnosis and management of COVID-19 disease. Am J Resp Crit Care Med. 2020. 10.1164/rccm.2020C1."},{"title3":"Pulmonary hypertension in severe acute respiratory failure"},{"title3":"Marini J, Gattinonni L. Management of COVID-19 respiratory distress. JAMA Published online April 24, 2020. doi:10.1001/jama.2020.6825."},{"title3":"Conservative fluid strategy or de-resuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State","References":[]},{"title2":"Clinical course and mortality risk of severe COVID-19","References":[{"title3":"Nursing Home Care in Crisis in the Wake of COVID-19"},{"title3":"The Long-Term Care COVID Tracker"},{"title3":"The Importance of Long-term Care Populations in Models of COVID-19"},{"title3":"The efficacy of social distance and ventilation effectiveness in preventing COVID-19 transmission"},{"title3":"Outbreak of COVID-19 in a nursing home associated with aerosol transmission as a result of inadequate ventilation"},{"title3":"&quot;Abandoned&quot; Nursing Homes Continue to Face Critical Supply and Staff Shortages as COVID-19 Toll Has Mounted"},{"title3":"Nursing homes and COVID-19: We can and should do better"},{"title3":"Centers for Medicare &amp; Medicaid Services: Trump Administration Issues Key Recommendations to Nursing Homes, State and Local Governments"},{"title3":"Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington"},{"title3":"Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans:Los Angeles, California, 2020"},{"title3":"Outbreak of COVID-19 in a nursing home in Madrid"},{"title3":"Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks-Minnesota, April-June 2020"},{"title3":"Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility"},{"title3":"Coronavirus disease 2019 (COVID-19) in long-term care facilities: A review of epidemiology, clinical presentations, and containment interventions"},{"title3":"Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility-King County, Washington, March 2020"},{"title3":"SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes"},{"title3":"Atypical clinical presentation of COVID-19 infection in residents of a long-term care facility"},{"title3":"COVID-19 in seniors: Findings and lessons from mass screening in a nursing home"},{"title3":"Outcomes of Nursing Home COVID-19 Patients by Initial Symptoms and Comorbidity: Results of Universal Testing of 1970 Residents"},{"title3":"Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors"},{"title3":"Risk Factors, Presentation, and Course of Coronavirus Disease 2019 in a Large, Academic Long-Term Care Facility"},{"title3":"Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility"},{"title3":"COVID-19 mortality risk factors in older people in a long-term care center"},{"title3":"Fever in the elderly"},{"title3":"The implications of silent transmission for the control of COVID-19 outbreaks"},{"title3":"COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China"},{"title3":"One is the deadliest number: The detrimental effects of social isolation on cerebrovascular diseases and cognition"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic"},{"title3":"Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports"},{"title3":"Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis"},{"title3":"Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID-19"},{"title3":"High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020"},{"title3":"Increased risk of SARS-CoV-2 infection in staff working across different care homes: Enhanced CoVID-19 outbreak investigations in London care Homes"},{"title3":"Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada"},{"title3":"It is Time to Address Airborne Transmission of COVID-19"},{"title3":"Association Between CMS Quality Ratings and COVID-19 Outbreaks in Nursing Homes:West Virginia, March 17-June 11, 2020"},{"title3":"Association of Nursing Home Ratings on Health Inspections, Quality of Care, and Nurse Staffing With COVID-19 Cases"},{"title3":"Is There a Link between Nursing Home Reported Quality and COVID-19 Cases? Evidence from California Skilled Nursing Facilities"},{"title3":"COVID-19 Infections and Deaths among Connecticut Nursing Home Residents: Facility Correlates"}]},{"title2":"Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study","References":[{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Covid-19 in critically ill patients in the Seattle region - case series"},{"title3":"Covid-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trials"},{"title3":"Ventilatory ratio: a simple bedside measure of ventilation"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"Prone position augments recruitment and prevents alveolar overinflation in acute lung injury"}]},{"title2":"Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group","References":[]},{"title2":"The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice","References":[]},{"title2":"Intubation and ventilation amid the COVID-19 outbreak","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Responding to COVID-19:A once-in-a-century pandemic?"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study."},{"title3":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: A retrospective case series study."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention."},{"title3":"Expert recommendations for tracheal intubation in critically ill patients with noval coronavirus disease 2019."},{"title3":"Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients."},{"title3":"Critical care crisis and some recommendations during the COVID-19 epidemic in China."},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]."},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review."},{"title3":"Intubation of SARS patients: Infection and perspectives of healthcare workers."},{"title3":"Should noninvasive ventilation be considered a high-risk procedure during an epidemic?"},{"title3":"Can breathing circuit filters help prevent the spread of influenza A (H1N1) virus from intubated patients?"},{"title3":"Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients."},{"title3":"Effect of preoxygenation using non-invasive ventilation before intubation on subsequent organ failures in hypoxaemic patients: A randomised clinical trial."},{"title3":"Critically ill patients with Middle East respiratory syndrome coronavirus infection."},{"title3":"Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients."},{"title3":"The optimal dose of remifentanil for acceptable intubating conditions during propofol induction without neuromuscular blockade."},{"title3":"Tussive effect of a fentanyl bolus administered through a central venous catheter."},{"title3":"Efficacy of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal surgery."},{"title3":"Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation."},{"title3":"Blood-pressure and pulse-rate responses to endotracheal extubation with and without prior injection of lidocaine."},{"title3":"A comparative study between the effects of 4% endotracheal tube cuff lignocaine and 1.5 mg/kg intravenous lignocaine on coughing and hemodynamics during extubation in neurosurgical patients: A randomized controlled double-blind trial."},{"title3":"Alfentanil suppresses coughing and agitation during emergence from isoflurane anesthesia."},{"title3":"Mechanisms of ventilator-induced lung injury."},{"title3":"Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016."},{"title3":"An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome."},{"title3":"Lung protective ventilation strategy for the acute respiratory distress syndrome."},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome."},{"title3":"Ventilatory management of acute respiratory distress syndrome: A consensus of two."},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome."},{"title3":"Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS)."},{"title3":"Ventilator management for hypoxemic respiratory failure attributable to H1N1 novel swine origin influenza virus."},{"title3":"High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome."},{"title3":"Nursing and infection-control issues during high-frequency oscillatory ventilation."},{"title3":"Work of breathing during lung-protective ventilation in patients with acute lung injury and acute respiratory distress syndrome: A comparison between volume and pressure-regulated breathing modes."},{"title3":"Ventilator management for acute respiratory distress syndrome associated with avian influenza A (H7N9) virus infection: A case series."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Lung recruitment maneuvers for ARDS patients: A systematic review and meta-analysis."},{"title3":"Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation."},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Neuromuscular blockade in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials."},{"title3":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) v influenza A infection."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: An updated Cochrane systematic review and meta-analysis."},{"title3":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial."},{"title3":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome."},{"title3":"Extracorporeal life support: The next step in moderate to severe ARDS-A review and meta-analysis of the literature."},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial."},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome."},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial."},{"title3":"A novel coronavirus outbreak of global health concern."},{"title3":"A review of isolation gowns in healthcare: Fabric and gown properties."},{"title3":"Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis."},{"title3":"Prone positioning in patients with moderate and severe acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Prone position for acute respiratory failure in adults."},{"title3":"Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation."},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: A report of nosocomial transmission."}]},{"title2":"Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report:81"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients with Lung Cancer"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19"},{"title3":"Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia"},{"title3":"Expert recommendations for tracheal intubation in critically ill patients with novel coronavirus disease 2019"},{"title3":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients"},{"title3":"Management of corona virus disease-19 (COVID-19): the Zhejiang experience"},{"title3":"Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience"},{"title3":"Perioperative management of patients infected with the novel coronavirus: recommendation from the joint task force of the Chinese society of anesthesiology and the Chinese association of anesthesiologists"},{"title3":"A clinical sign to predict difficult tracheal intubation: a prospective study"},{"title3":"Assessment of coma and impaired consciousness. A practical scale"},{"title3":"Difficult tracheal intubation in obstetrics"},{"title3":"The physiologically difficult airway"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Consensus statement: safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group"},{"title3":"Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists"},{"title3":"High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial"},{"title3":"Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood"},{"title3":"Potential association between COVID-19 mortality and health-care resource availability"},{"title3":"If nothing goes wrong, is everything all right? Interpreting zero numerators"},{"title3":"SARS safety and science"},{"title3":"Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff"},{"title3":"Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies"},{"title3":"Duration of adrenal inhibition following a single dose of etomidate in critically ill patients"},{"title3":"Videolaryngoscopy increases 'mouth-to-mouth' distance compared with direct laryngoscopy"},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation"},{"title3":"Supraglottic jet oxygenation and ventilation-assisted fibre-optic bronchoscope intubation in patients with difficult airways"},{"title3":"Supraglottic jet oxygenation and ventilation:a novel ventilation technique"},{"title3":"Comparison of Macintosh laryngoscopy in bed-up-head-elevated position with GlideScope laryngoscopy: a randomized, controlled, noninferiority trial"},{"title3":"Head-elevated patient positioning decreases complications of emergent tracheal intubation in the ward and intensive care unit"},{"title3":"Is infection and septic shock caused by a global oxygen deficiency? An overview in 2 parts. 1: infection and correlation between DO2 and VO2"},{"title3":"Critical care crisis and some recommendations during the COVID-19 epidemic in China"},{"title3":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients"},{"title3":"SARS: ventilatory and intensive care"},{"title3":"Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure"},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Respiratory support for patients with COVID-19 infection"},{"title3":"Comparison of high-flow nasal cannula oxygen therapy and non-invasive ventilation as first-line therapy in respiratory failure: a multicenter retrospective study"},{"title3":"High-flow oxygen therapy and other inhaled therapies in intensive care units"},{"title3":"Preoxygenation and prevention of desaturation during emergency airway management"},{"title3":"High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: a review and meta-analysis"},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways"},{"title3":"Incidence of and risk factors for post-intubation hypotension in the critically ill"},{"title3":"Predictors of hemodynamic derangement during intubation in the critically ill: a nested case-control study of hemodynamic management:part II"},{"title3":"Airway challenges in critical care"},{"title3":"Cardiac arrest and mortality related to intubation procedure in critically ill adult patients: a multicenter cohort study"},{"title3":"Automated prone positioning and axial rotation in critically ill, nontrauma patients with acute respiratory distress syndrome (ARDS)"}]},{"title2":"Kidney-lung pathophysiological crosstalk: its characteristics and importance","References":[]},{"title2":"COVID: the new ultrasound alphabet in SARS-CoV-2 era","References":[{"title3":"The ultrasound guided triage: a new tool for prehospital management of COVID-19 pandemic"},{"title3":"The Italian coronavirus disease 2019 outbreak: experiences and recommendations from clinical practice"},{"title3":"Renal resistive index: a new reversible tool for the early diagnosis and evaluation of organ perfusion in critically ill patients: a case report"},{"title3":"Renal doppler resistive index as a marker of oxygen supply and demand mismatch in postoperative cardiac surgery patients"},{"title3":"Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area"},{"title3":"Application of lung ultrasound during the COVID-19 pandemic: a narrative review"},{"title3":"Evaluation of two neck ultrasound measurements as predictors of difficult direct laryngoscopy: a prospective observational study"}]},{"title2":"Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study"},{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study"},{"title3":"Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan"},{"title3":"Clinical course and outcomes of 344 intensive care patients with COVID-19"},{"title3":"Standardized protocol of prone position ventilation in patients with acute respiratory distress syndrome"},{"title3":"Treatment of ARDS with prone positioning"},{"title3":"Prone position in ARDS patients: why, when, how and for whom"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"Prone position for acute respiratory failure in adults"},{"title3":"Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis"},{"title3":"Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study"},{"title3":"Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study"},{"title3":"Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study"},{"title3":"Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit"},{"title3":"Awake Prone Positioning in Non-Intubated Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19"},{"title3":"Effect of prone versus supine position in COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Effect of prone positioning on clinical outcomes of non-intubated subjects with COVID-19: a comparative systematic review and meta-analysis"},{"title3":"Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial"},{"title3":"Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial"},{"title3":"Assessment of awake prone positioning in hospitalized adults with COVID-19: a nonrandomized controlled trial"},{"title3":"Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial"},{"title3":"Prone positioning of patients with moderate hypoxaemia due to COVID-19: multicentre pragmatic randomised trial (COVID-PRONE)"},{"title3":"Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update"},{"title3":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial"},{"title3":"Standard care versus awake prone position in adult nonintubated patients with acute hypoxemic respiratory failure secondary to COVID-19 infection:a multicenter feasibility randomized controlled trial"},{"title3":"Patient-directed prone positioning in awake patients with COVID-19 requiring hospitalization (PAPR)"},{"title3":"Effect of prone positioning on the respiratory support of nonintubated patients with COVID-19 and acute hypoxemic respiratory failure: a retrospective matching cohort study"},{"title3":"Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study"},{"title3":"Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: a retrospective multicenter cohort study"},{"title3":"Effect of proning in patients with COVID-19 acute hypoxemic respiratory failure receiving noninvasive oxygen therapy"},{"title3":"Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study"},{"title3":"Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study"},{"title3":"Impact of prone position in non-intubated spontaneously breathing patients admitted to the ICU for severe acute respiratory failure due to COVID-19"},{"title3":"Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19"},{"title3":"Effect of early awake prone positioning application on prognosis in patients with acute respiratory failure due to COVID-19 pneumonia: a retrospective observational study"},{"title3":"Awake-prone positioning strategy for non-intubated hypoxic patients with COVID-19: a pilot trial with embedded implementation evaluation"},{"title3":"Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study"},{"title3":"Efficacy of early prone or lateral positioning in patients with severe COVID-19: a single-center prospective cohort"},{"title3":"The POSITIONED study: prone positioning in nonventilated coronavirus disease 2019 patients-a retrospective analysis"},{"title3":"Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study"},{"title3":"Prone positioning in awake, nonintubated patients with COVID-19: necessity is the mother of invention"},{"title3":"Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives"},{"title3":"Prone position in acute respiratory distress syndrome. Rationale, indications, and limits"},{"title3":"Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome"},{"title3":"Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis"},{"title3":"Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Predictors of survival in patients with influenza pneumonia-related severe acute respiratory distress syndrome treated with prone positioning"},{"title3":"Decrease in PaCO2 with prone position is predictive of improved outcome in acute respiratory distress syndrome"},{"title3":"Factors influencing prone positioning in treating acute respiratory distress syndrome and the effect on mortality rate"},{"title3":"Early versus late awake prone positioning in non-intubated patients with COVID-19"},{"title3":"A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome"},{"title3":"Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]}]},{"title1":"Case characteristics, resource use, and outcomes of 10?021 patients with COVID-19 admitted to 920 German hospitals: an observational study","References":[{"title2":"Coronavirus disease 2019 (COVID-19) daily situation report of the Robert Koch Institute","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of patients who died of coronavirus disease 2019 in China","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Bulletin of the National Health Commission of the People's Republic of China on the 2019 new coronavirus infection. Accessed March 8, 2020. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Accessed March 8, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"Noninvasive ventilation for acute respiratory failure"},{"title3":"The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"COVID-19 infecties op de verpleegafdeling","References":[]},{"title2":"Point epidemiologique hebdomadaire du 21 mai 2020","References":[]},{"title2":"Situacion de COVID-19 en Espana","References":[]},{"title2":"COVID-19:wekelijks epidemiologisch bulletin van 22 mei 2020","References":[]},{"title2":"Variation in COVID-19 hospitalizations and deaths across New York City boroughs","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalised with severe COVID-19","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","References":[{"title3":"WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"title3":"WHO. WHO coronavirus disease 2019 (covid-19) situation report-101. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2."},{"title3":"The UK's pandemic influenza research portfolio: a model for future research on emerging infections"},{"title3":"Estimates of the severity of coronavirus disease 2019: a model-based analysis"},{"title3":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection"},{"title3":"WHO. WHO preliminary clinical description of severe acute respiratory syndrome. 2003.https://www.who.int/csr/sars/clinical/en/."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area"},{"title3":"Clarification of mortality rate and data in abstract, results, and table 2"},{"title3":"Conolly A, Craig S. Health survey for England 2018: overweight and obesity in adults and children. 2019. https://files.digital.nhs.uk/52/FD7E18/HSE18-Adult-Child-Obesity-rep.pdf."},{"title3":"Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK"},{"title3":"Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)"},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Host susceptibility to severe influenza A virus infection"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"ICNARC. ICNARC report on COVID-19 in critical care. 2020:1-9. https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports."},{"title3":"ISARIC4C. ISARIC Coronavirus Clinical Characterisation Consortium. 2020. https://isaric4c.net/."},{"title3":"GOV.UK. New and Emerging Respiratory Virus Threats Advisory Group. 2020. https://www.gov.uk/government/groups/new-and-emerging-respiratory-virus-threats-advisory-group."},{"title3":"GOV.UK. Scientific Advisory Group for Emergencies. 2020. https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response."},{"title3":"GOV.UK. Scientific Pandemic Influenza Group on Modelling. 2020. https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling."}]},{"title2":"Mechanical ventilation in COVID-19: interpreting the current epidemiology","References":[{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Clinical course and outcomes of 344 intensive care patients with COVID-19"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area"},{"title3":"Noninvasive ventilation of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study"},{"title3":"Evidence-based utilization of noninvasive ventilation and patient outcomes"},{"title3":"Variation in critical care services across North America and Western Europe"},{"title3":"Use of intensive care services during terminal hospitalizations in England and the United States"},{"title3":"Comparison of medical admissions to intensive care units in the United States and United Kingdom"},{"title3":"Association between immigrant status and end-of-life care in Ontario, Canada"},{"title3":"Noninvasive ventilation in acute cardiogenic pulmonary edema"},{"title3":"Clinical characteristics of patients who died of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of covid-19 in New York City"},{"title3":"ICNARC report on COVID-19 in critical care"},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response"},{"title3":"The epidemiology of mechanical ventilation use in the United States"},{"title3":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York city [preprint]"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"}]},{"title2":"Gesetzliche Krankenversicherung: Mitglieder, mitversicherte Angehorige und Krankenstand: Monatswerte Januar-April 2020","References":[]},{"title2":"Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition","References":[]},{"title2":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","References":[]},{"title2":"Comorbidity measures for use with administrative data","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"ICNARC report on COVID-19 in critical care","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit &amp; Research Centre Case Mix Programme Database"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Development and validation of the new ICNARC model for prediction of acute hospital mortality in adult critical care"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Early observational research and registries during the 2009-2010 influenza A pandemic"},{"title3":"The Swine Flu Triage (SwiFT) study: development and ongoing refinement of a triage tool to provide regular information to guide immediate policy and practice for the use of critical care services during the H1N1 swine influenza pandemic"},{"title3":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Clinical characteristics of patients who died of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"Multiorgan and renal tropism of SARS-CoV-2","References":[{"title3":"Coronavirus disease 2019 (COVID-2019): situation report : 51."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes."},{"title3":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China."},{"title3":"Renal involvement and early prognosis in patients with COVID-19 pneumonia."}]},{"title2":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","References":[{"title3":"WHO announces COVID-19 outbreak a pandemic"},{"title3":"Offline: COVID-19 and the NHS-&quot;a national scandal&quot;"},{"title3":"We asked the experts: Covid-19 outbreak: is there still a place for scheduled surgery? &quot;Reflection from pathophysiological data&quot;"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study"},{"title3":"The LAS VEGAS risk score for prediction of postoperative pulmonary complications: an observational study"},{"title3":"Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer"},{"title3":"Fourth patient report of the National Emergency Laparotomy Audit"},{"title3":"Surgery in COVID-19 patients: operational directives"},{"title3":"Global guidance for surgical care during the COVID-19 pandemic"},{"title3":"Recommendations for general surgery clinical practice in novel coronavirus pneumonia situation"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications"},{"title3":"The Prevention of Respiratory Insufficiency after Surgical Management (PRISM) Trial. Report of the protocol for a pragmatic randomized controlled trial of CPAP to prevent respiratory complications and improve survival following major abdominal surgery"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"COVID-19: guidance for triage of non-emergent surgical procedures"},{"title3":"Fifth patient report of the National Emergency Laparotomy Audit"},{"title3":"Mortality of emergency abdominal surgery in high-, middle- and low-income countries"},{"title3":"ICNARC report on COVID-19 in critical care"},{"title3":"Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study"},{"title3":"Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators"},{"title3":"Gastrointestinal complications in critically ill patients with COVID-19"},{"title3":"COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period"},{"title3":"Performing abdominal surgery during the COVID-19 epidemic in Wuhan, China: a single-centred, retrospective, observational study"},{"title3":"Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"}]},{"title2":"Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study","References":[{"title3":"How much 'normal' risk does Covid represent? Medium"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020"},{"title3":"Deaths registered weekly in England and Wales, provisional: week ending 3 April 2020"},{"title3":"Coronavirus disease 2019 (COVID-19). People who are at higher risk"},{"title3":"Guidance on social distancing for everyone in the UK"},{"title3":"Major new measures to protect people at highest risk from coronavirus"},{"title3":"UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER"},{"title3":"A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service"},{"title3":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1 25 million people"},{"title3":"Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records"},{"title3":"Global Alliance for Chronic Disease researchers' statement on multimorbidity"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19"},{"title3":"Real estimates of mortality following COVID-19 infection"},{"title3":"Coronavirus could kill half a million Britons and infect 80% of UK population, government documents indicate"},{"title3":"Deaths by single year of age tables, UK"},{"title3":"World population dashboard"},{"title3":"What China's coronavirus response can teach the rest of the world"},{"title3":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey"},{"title3":"Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes"},{"title3":"Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review"},{"title3":"Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction"},{"title3":"Critical Care Health Informatics Collaborative (CCHIC): data, tools and methods for reproducible research: a multi-centre UK intensive care database"},{"title3":"Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres"},{"title3":"Economic considerations for social distancing and behavioral based policies during an epidemic"},{"title3":"Coronavirus: UK deaths double in 24 hours"}]},{"title2":"Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008","References":[]},{"title2":"Acute kidney injury: prevention, detection and management","References":[]},{"title2":"EuroELSO survey on ECMO use in adult COVID-19 patients in Europe","References":[]},{"title2":"Estimating the burden of SARS-CoV-2 in France","References":[]},{"title2":"Beyond containment: health systems responses to COVID-19 in the OECD","References":[]}]},{"title1":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","References":[{"title2":"REVA network http://www.reseau-reva.org/. Accessed 5 Oct 2020","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Available at https://covid19.who.int. Accessed 19 July 2020"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Covid-19 in critically ill patients in the Seattle region:case series"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Diagnosis and management protocol of COVID-19 in China. https://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml"},{"title3":"Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS"},{"title3":"Moreno R, Vincent JL, Matos R, Mendonca A,Cantraine F, Thijs L , Sprung C,Antonelli M, Bruining and medicine H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. In': Working group on sepsis related problems of the ESICM25, pp 686-696"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"TIme-varying covariates and coefficients in Cox regression models"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Severe acute respiratory distress syndrome (SARS): a critical care perspective"},{"title3":"Outcomes of severe H1N1 pneumoniae: a retrospective study at intensive care units"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"WHO. Clinical management of COVID-19: interim guidance, 27 May 2020. Available at https://apps.who.int/iris/rest/bitstreams/1278777/retrieve. Accessed 22 June 2020"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality"},{"title3":"The Heart in COVID19: Primary target or secondary bystander?"},{"title3":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) Virus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"15-day mortality and associated risk factors for hospitalized patients with COVD-19 in Wuhan, China: an ambispective observational cohort study"},{"title3":"A severe sepsis mortality prediction model and score for use with administrative data"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angles-Cano E, Sattler L, Mertes PM, Meziani F, CRICS TRIGGERSEP Group (2020) High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089-1098"},{"title3":"Clinical characteristics of patients who died of coronavirus disease 2019 in China"}]},{"title2":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","References":[]},{"title2":"Dexamethasone in hospitalized patients with Covid-19:preliminary report","References":[]},{"title2":"Clinical management of severe acute respiratory infection when COVID-19 is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed 27 Apr 2020","References":[]},{"title2":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study","References":[]},{"title2":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","References":[]},{"title2":"Clinical frailty scale in an acute medicine unit: a simple tool that predicts length of stay","References":[{"title3":"The impact of frailty and delirium on mortality in older inpatients"},{"title3":"Change in disability after hospitalization or restricted activity in older persons"},{"title3":"Prevalence of frailty and its ability to predict in hospital delirium, falls, and 6-month mortality in hospitalized older patients"},{"title3":"Frailty in older adults: evidence for a phenotype"},{"title3":"Prevalence of frailty in community- dwelling older persons: a systematic review"},{"title3":"Frailty and health related quality of life among residents of long-term care facilities"},{"title3":"Assessing frailty in acute medical admission of elderly patients"},{"title3":"The risk of adverse outcomes in hospitalized older patients in relation to a frailty index based on a comprehensive geriatric assessment"},{"title3":"Frailty is associated with longer hospital stay and increased mortality in hospitalized older patients"},{"title3":"A global clinical measure of fitness and frailty in elderly people"},{"title3":"Facilitating frailty identification: comparison of two methods among community-dwelling older adults"},{"title3":"The frailty pheonotype and the frailty index: different instruments for different purposes"},{"title3":"Frailty in an older inpatient population: using the clinical frailty scale to predict patient outcomes"},{"title3":"Early ambulation and length of stay in older adults hospitalized for acute illness"},{"title3":"Multidimensional frailty score for the prediction of postoperative mortality risk"},{"title3":"Relationship between frailty and discharge outcomes in subacute care"},{"title3":"Frailty and outcome in elderly patients with acute coronary syndrome"},{"title3":"Impact of frailty on length of hospital stay after percutaneous coronary intervention [abstract]"},{"title3":"The ability of frailty to predict outcomes in older people attending an acute medical unit"},{"title3":"Association of the clinical frailty scale with hospital outcomes"},{"title3":"Association between frailty and 30-day outcomes after discharge from hospital [Internet]"},{"title3":"Frailty in an older inpatient population: using the clinical frailty scale to predict patient outcomes"},{"title3":"Identifying mobility heterogeneity in frail older adults. Are frail people all the same?"}]},{"title2":"Ventilator-related causes of lung injury: the mechanical power","References":[]},{"title2":"Physiological analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"International study of the prevalence and outcomes of infection in intensive care units","References":[]},{"title2":"Proportional hazards tests and diagnostics based on weighted residuals","References":[]},{"title2":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","References":[]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","References":[{"title3":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. The American review of respiratory disease"},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome"},{"title3":"Lung inhomogeneity in patients with acute respiratory distress syndrome"},{"title3":"Respiratory drive in critically ill patients. Pathophysiology and clinical implications"},{"title3":"Positive pressure respiration and its application to the treatment of acute pulmonary edema"},{"title3":"Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study"},{"title3":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure"},{"title3":"Vertical gradient of regional lung inflation in adult respiratory distress syndrome"},{"title3":"Reclassifying acute respiratory distress syndrome"},{"title3":"Targeting transpulmonary pressure to prevent ventilator-induced lung injury"},{"title3":"A comparison of oesophageal and central venous pressures in the measurement of transpulmonary pressure change"}]},{"title2":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"COVID-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Management of COVID-19 respiratory distress"},{"title3":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome"},{"title3":"Alterations of lung and chest wall mechanics in patients with acute lung injury: effects of positive end-expiratory pressure"},{"title3":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations"},{"title3":"Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation"},{"title3":"Stand-alone performance of a computer-assisted detection prototype for detection of acute pulmonary embolism: a multi-institutional comparison"},{"title3":"Missed pulmonary emboli on CT angiography: assessment with pulmonary embolism-computer-aided detection"},{"title3":"Physiologic analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome"},{"title3":"Elevated plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility"},{"title3":"Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury"},{"title3":"Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy"},{"title3":"Early bedside detection of pulmonary vascular occlusion during acute respiratory failure"},{"title3":"Pulmonary hypertension in severe acute respiratory failure"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury"},{"title3":"COVID-19 pneumonia: ARDS or not?"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Lung recruitability in COVID-19-associated acute respiratory distress syndrome: a single-center, observational study"},{"title3":"Covid-19 in critically ill patients in the Seattle region:case series"},{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"Respiratory mechanics and gas exchange in COVID-19 associated respiratory failure"},{"title3":"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS"},{"title3":"Pandemic H1N1 influenza infection and vascular thrombosis"},{"title3":"Treatment for severe acute respiratory distress syndrome from COVID-19"},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis"}]},{"title2":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts","References":[]},{"title2":"The baby lung and the COVID-19 era","References":[{"title3":"Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study"},{"title3":"The prone position in ARDS patients. A clinical study"},{"title3":"Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure"},{"title3":"The ARDS lung. New insights from computed tomography"},{"title3":"COVID-19: a novel coronavirus and a novel challenge for critical care"},{"title3":"Covid-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"COVID-19 pneumonia: different respiratory treatment for different phenotypes"},{"title3":"Time course of evolving ventilator-induced lung injury: the &quot;Shrinking Baby Lung&quot;"},{"title3":"Ventilator-related causes of lung injury: the mechanical power"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Lung inhomogeneities and time course of ventilator-induced mechanical injuries"},{"title3":"Ventilation-induced lung injury exists in spontaneously breathing patients with acute respiratory failure: yes"},{"title3":"Vertical gradient of regional lung inflation in adult respiratory distress syndrome"},{"title3":"Lung inhomogeneities, inflation and [18F]2-fluoro-2-deoxy-d-glucose uptake rate in acute respiratory distress syndrome"},{"title3":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts"}]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study","References":[{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: a multicenter descriptive study"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 disease is suspected"},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)"},{"title3":"Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: any impact on their outcomes?"},{"title3":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective single center cohort study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Severe pulmonary embolism in COVID-19 patients: a call for increased awareness"},{"title3":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort"},{"title3":"Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"},{"title3":"Ventilator-related causes of lung injury: the mechanical power"},{"title3":"Physiologic analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Formal guidelines: management of acute respiratory distress syndrome"},{"title3":"Extracorporeal life support for adults with respiratory failure and related indications: a review"},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome"},{"title3":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis"},{"title3":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence"},{"title3":"Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock"}]},{"title2":"Apples and oranges: international comparisons of COVID-19 observational studies in ICUs","References":[{"title3":"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS"},{"title3":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study"},{"title3":"Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies"},{"title3":"Critical care capacity during the COVID-19 pandemic: global availability of intensive care beds"},{"title3":"A minimal common outcome measure set for COVID-19 clinical research"},{"title3":"Between-centre differences for COVID-19 ICU mortality from early data in England"},{"title3":"Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study"},{"title3":"Dexamethasone in hospitalized patients with COVID-19 - preliminary report"}]},{"title2":"Declines in mortality over time for critically ill adults with coronavirus disease 2019","References":[{"title3":"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019"},{"title3":"Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Remdesivir for the Treatment of Covid-19 - Preliminary Report"},{"title3":"The RECOVERY Platform"},{"title3":"Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies"}]},{"title2":"ICU capacity management during the COVID-19 pandemic using a process simulation","References":[{"title3":"Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster"},{"title3":"The variability of critical care bed numbers in Europe"},{"title3":"Alban A, Chick SE, Dongelmans DA, Van der Sluijs AF, Wiersinga WJ, Vlaar APJ, Sent D (2020) ICU capacity management during the COVID-19 pandemic using a stochastic process simulation. https://ssrn.com/abstract=3570406, source code at https://github.com/sechick/icu-covid-sim/"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"}]},{"title2":"Acute kidney injury in critically ill patients with COVID-19","References":[{"title3":"Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE). Accessed 13th December 2022, https://coronavirus.jhu.edu/map.html"},{"title3":"Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol"},{"title3":"Acute kidney injury in patients hospitalized with COVID-19"},{"title3":"AKI in hospitalized patients with COVID-19"},{"title3":"Pathophysiology of COVID-19-associated acute kidney injury"},{"title3":"Outcomes among patients hospitalized with COVID-19 and acute kidney injury"},{"title3":"Kidney disease is associated with in-hospital death of patients with COVID-19"},{"title3":"John Hopkins University Coronavirus Resource Center. Mortality Analyses Updated November 23rd 2022]. Accessed November 24th 2022. https://coronavirus.jhu.edu/data/mortality"},{"title3":"Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study"},{"title3":"World Incidence of AKI: A Meta-Analysis"},{"title3":"Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ : British Medical Journal (Online). 2019 Oct 31 2019-11-02 2019;367doi:http://dx.doi.org/10.1136/bmj.l5873"},{"title3":"Chavez-Iniguez JS, Cano-Cervantes JH, Maggiani-Aguilera P, et al. Mortality and evolution between community and hospital-acquired COVID-AKI. PLoS One. 2021;16(11):e0257619. doi:10.1371/journal.pone.0257619"},{"title3":"Clinical profile and outcomes of COVID-19 patients with acute kidney injury: a tertiary centre experience from South India"},{"title3":"ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19"},{"title3":"ISARIC. Clinical Characterisation Protocol (CCP). https://isaric.org/research/covid-19-clinical-research-resources/clinical-characterisation-protocol-ccp/"},{"title3":"Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020:m1985. doi:10.1136/bmj.m1985"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Workgroup. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int Suppl (2011). 2012;2(1):1-138."},{"title3":"Wasserman L. All of statistics : a concise course in statistical inference. Chapter 10: Hypothesis testing and p-values. Springer New York : Imprint: Springer; 2004."},{"title3":"Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets"},{"title3":"Nonparametric estimation from incomplete observations"},{"title3":"R. Core Team. R: A Language and Environment for Statistical Computing. 2021."},{"title3":"Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. https://doi.org/10.21105/joss.01686. Journal of Open Source Software. 2019;4(43):1686-1686."},{"title3":"Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020;16(5):251-251."},{"title3":"Geetha D, Kronbichler A, Rutter M, et al. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol. 2022/11/01 2022;18(11):724-737. doi:10.1038/s41581-022-00618-4"},{"title3":"Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium"},{"title3":"Martinez-Rueda AJ, Alvarez RD, Mendez-Perez RA, et al. Community- and Hospital-Acquired Acute Kidney Injury in COVID-19: Different Phenotypes and Dismal Prognosis. Blood Purif. 2021;50(6):931-941. doi:10.1159/000513948"},{"title3":"Acute kidney injury during the COVID-19 pandemic - experience from two tertiary centres in South Africa"},{"title3":"Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and Pakistan"},{"title3":"Yaqub S, Hamid A, Saeed M, Awan S. MO310: Clinical Characteristics and Outcomes of Acute Kidney Injury in Hospitalized Patients With COVID-19: Experience at a Major Tertiary Care Center in Pakistan. Nephrol Dial Transplant. 2022;37(Supplement_3)doi:10.1093/ndt/gfac068.020"},{"title3":"Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019"},{"title3":"Latin American registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course"},{"title3":"Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study"},{"title3":"Macedo E, Hemmila U, Sharma SK, et al. Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study. PLoS Med. 2021Jan 14;18(1):e1003408. doi:10.1371/journal.pmed.1003408"},{"title3":"Pragmatic Recommendations for the Prevention and Treatment of Acute Kidney Injury in Patients with COVID-19 in Low- and Middle-Income Countries"},{"title3":"Acute kidney injury requiring renal replacement therapy during the COVID-19 pandemic: what are our options for treating it in Latin America?"},{"title3":"The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries - An ISN/DOPPS Survey"},{"title3":"International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology"},{"title3":"Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications"},{"title3":"Understanding how socioeconomic inequalities drive inequalities in COVID-19 infections"},{"title3":"COVID-19 vaccines for low-and middle-income countries"},{"title3":"Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19"}]},{"title2":"https://www.santepubliquefrance.fr/les-actualites/2017/etude-esteban-2014-2016-chapitre-corpulence-stabilisation-du-surpoids-et-de-l-obesite-chez-l-enfant-et-l-adulte. Accessed 5 Oct 2020","References":[]},{"title2":"Obesity impairs the adaptive immune response to influenza virus","References":[]},{"title2":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","References":[{"title3":"Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999-2010"},{"title3":"The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies"},{"title3":"Overweight and obesity in the United States: prevalence and trends, 1960-1994"},{"title3":"Prevalence of overweight and obesity among adults with diagnosed diabetes-United States, 1988-1994 and 1999-2002"},{"title3":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants"},{"title3":"Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus"},{"title3":"Diabetes mellitus, fasting glucose, and risk of cause-specific death"},{"title3":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association's strategic impact goal through 2020 and beyond"},{"title3":"Assessing adiposity: a scientific statement from the American heart association"},{"title3":"Excess weight and the risk of incident coronary heart disease among men and women"},{"title3":"Indices of abdominal obesity are better discriminators of cardiovascular risk factors than bmi: a meta-analysis"},{"title3":"Relationships between rodent white adipose fat pads and human white adipose fat depots"},{"title3":"Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes"},{"title3":"Role of a critical visceral adipose tissue threshold (cvatt) in metabolic syndrome: implications for controlling dietary carbohydrates: a review"},{"title3":"Heterogeneity of white adipose tissue: molecular basis and clinical implications"},{"title3":"Evidence for a role of developmental genes in the origin of obesity and body fat distribution"},{"title3":"Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study"},{"title3":"Formation of the epicardium studied with the scanning electron microscope"},{"title3":"Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart"},{"title3":"Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties"},{"title3":"Human epicardial adipose tissue is a source of inflammatory mediators"},{"title3":"Epicardial fat: from the biomolecular aspects to the clinical practice"},{"title3":"Perivascular adipose tissue: more than just structural support"},{"title3":"Perivascular adipose tissue (pvat) in atherosclerosis: a double-edged sword"},{"title3":"Portal Adipose tissue as a generator of risk factors for cardiovascular disease and diabetes"},{"title3":"An adipose tissue atlas: an image-guided identification of human-like bat and beige depots in rodents"},{"title3":"Brown adipose tissue: function and physiological significance"},{"title3":"Identification and importance of brown adipose tissue in adult humans"},{"title3":"Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist"},{"title3":"Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat"},{"title3":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome"},{"title3":"Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region"},{"title3":"Adipose tissue-derived signatures for obesity and type 2 diabetes: adipokines, batokines and micrornas"},{"title3":"Brown and brite: the fat soldiers in the anti-obesity fight"},{"title3":"Recruited vs. Nonrecruited molecular signatures of brown, Brite, and white adipose tissues"},{"title3":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human"},{"title3":"A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans"},{"title3":"Human bat possesses molecular signatures that resemble beige/brite cells"},{"title3":"Genetic and functional characterization of clonally derived adult human brown adipocytes"},{"title3":"Humans and mice display opposing patterns of Browning Gene expression in visceral and subcutaneous white adipose tissue depots"},{"title3":"Tumour-derived pth-related protein triggers adipose tissue browning and cancer cachexia"},{"title3":"Activation of natriuretic peptides and the sympathetic nervous system following roux-en-y gastric bypass is associated with gonadal adipose tissues browning"},{"title3":"Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress"},{"title3":"Metabolically distinct weight loss by 10,12 cla and caloric restriction highlight the importance of subcutaneous white adipose tissue for glucose homeostasis in mice"},{"title3":"Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate"},{"title3":"Appearance of brown adipocytes in white adipose tissue during cl 316,243-induced reversal of obesity and diabetes in zucker fa/fa rats"},{"title3":"Capsaicin induces browning of white adipose tissue and counters obesity by activating trpv1 channel-dependent mechanisms"},{"title3":"Green tea extract induces genes related to browning of white adipose tissue and limits weight-gain in high energy diet-fed rat"},{"title3":"Chronic peroxisome proliferator-activated receptor gamma (ppargamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, ucp1-containing adipocytes molecularly distinct from classic brown adipocytes"},{"title3":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms"},{"title3":"A new thiazolidinedione, nc-2100, which is a weak ppar-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of kkay obese mice"},{"title3":"Exercise effects on white adipose tissue: beiging and metabolic adaptations"},{"title3":"Prdm16 controls a brown fat/skeletal muscle switch"},{"title3":"Cellular origins of beige fat cells revisited"},{"title3":"The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation"},{"title3":"Transdifferentiation properties of adipocytes in the adipose organ"},{"title3":"Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance"},{"title3":"Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes"},{"title3":"Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity"},{"title3":"Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice"},{"title3":"Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice"},{"title3":"Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice"},{"title3":"Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program"},{"title3":"Mechanisms of obesity-associated insulin resistance: many choices on the menu"},{"title3":"Heterogeneity of adipose tissue in development and metabolic function"},{"title3":"Brown adipose tissue is linked to a distinct thermoregulatory response to mild cold in people"},{"title3":"Distribution and development of brown adipocytes in the murine and human adipose organ"},{"title3":"Recruited brown adipose tissue as an antiobesity agent in humans"},{"title3":"Brown and beige fat: development, function and therapeutic potential"},{"title3":"Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis"},{"title3":"Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat"},{"title3":"The metabolic er stress sensor ire1alpha suppresses alternative activation of macrophages and impairs energy expenditure in obesity"},{"title3":"Continuous cold exposure induces an anti-inflammatory response in mesenteric adipose tissue associated with catecholamine production and thermogenin expression in rats"},{"title3":"Injecting engineered anti-inflammatory macrophages therapeutically induces white adipose tissue browning and improves diet-induced insulin resistance"},{"title3":"Reducing rip140 expression in macrophage alters atm infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance"},{"title3":"Mitoneet-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity"},{"title3":"Mtorc2 signalling regulates m2 macrophage differentiation in response to helminth infection and adaptive thermogenesis"},{"title3":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity"},{"title3":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis"},{"title3":"Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis"},{"title3":"Adipokines and the peripheral and neural control of energy balance"},{"title3":"The long road to leptin"},{"title3":"20 years of leptin: human disorders of leptin action"},{"title3":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans"},{"title3":"Effect of fasting on serum leptin in normal human subjects"},{"title3":"Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans"},{"title3":"Adipoq is a novel adipose-specific gene dysregulated in obesity"},{"title3":"Cdna cloning and expression of a novel adipose specific collagen-like factor, apm1 (adipose most abundant gene transcript 1)"},{"title3":"Isolation and characterization of gbp28, a novel gelatin-binding protein purified from human plasma"},{"title3":"A novel serum protein similar to c1q, produced exclusively in adipocytes"},{"title3":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex"},{"title3":"Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression"},{"title3":"Relationships between circulating adiponectin levels and fat distribution in obese subjects"},{"title3":"Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes"},{"title3":"Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects"},{"title3":"Diet-induced insulin resistance in mice lacking adiponectin/acrp30"},{"title3":"Obesity-associated improvements in metabolic profile through expansion of adipose tissue"},{"title3":"cloning of adiponectin receptors that mediate antidiabetic metabolic effects"},{"title3":"Adiponectin regulation and function"},{"title3":"Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets"},{"title3":"Molecular mechanism for adiponectin-dependent m2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin"},{"title3":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells"},{"title3":"Resistin: functional roles and therapeutic considerations for cardiovascular disease"},{"title3":"Resistin / fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans"},{"title3":"Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women"},{"title3":"The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications"},{"title3":"Resistin in rodents and humans"},{"title3":"The hormone resistin links obesity to diabetes"},{"title3":"Resistin is expressed in human hepatocytes and induces insulin resistance"},{"title3":"Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans"},{"title3":"Serum resistin (fizz3) protein is increased in obese humans"},{"title3":"Resistin, central obesity, and type 2 diabetes"},{"title3":"Increased resistin gene and protein expression in human abdominal adipose tissue"},{"title3":"Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines"},{"title3":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists"},{"title3":"Resistin gene expression in human adipocytes is not related to insulin resistance"},{"title3":"Resistin: a new link between obesity and insulin resistance?"},{"title3":"Resistin, an adipokine with potent proinflammatory properties"},{"title3":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action"},{"title3":"Relevance of leptin and other adipokines in obesity-associated cardiovascular risk"},{"title3":"Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue"},{"title3":"New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women"},{"title3":"Omentin plasma levels and gene expression are decreased in obesity"},{"title3":"Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes"},{"title3":"Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose"},{"title3":"[Expression of omentin in adipose tissues in obese and type 2 diabetic patients]"},{"title3":"Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters"},{"title3":"Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome"},{"title3":"Circulating omentin concentration increases after weight loss"},{"title3":"Omentin, a novel adipocytokine inhibits tnf-induced vascular inflammation in human endothelial cells"},{"title3":"Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells"},{"title3":"A novel adipocytokine, omentin, inhibits platelet-derived growth factor-bb-induced vascular smooth muscle cell migration through antioxidative mechanism"},{"title3":"Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4/MyD88/NF-kappaB signaling"},{"title3":"Adipocytokine, omentin inhibits doxorubicin-induced h9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species"},{"title3":"Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells"},{"title3":"Modulatory role of omentin-1 in inflammation: cytokines and dietary intake"},{"title3":"Omentin as a novel biomarker of metabolic risk factors"},{"title3":"The role of fibroblast growth factor 21 (fgf21) on energy balance, glucose and lipid metabolism"},{"title3":"Fibroblast growth factor 21 corrects obesity in mice"},{"title3":"Circulating fgf21 is liver derived and enhances glucose uptake during refeeding and overfeeding"},{"title3":"Fgf21 regulates metabolism through adipose-dependent and -independent mechanisms"},{"title3":"A long-acting fgf21 molecule, pf-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects"},{"title3":"fgf21 is an akt-regulated myokine"},{"title3":"metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues"},{"title3":"Serum fgf21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans"},{"title3":"Obesity is a fibroblast growth factor 21 (fgf21)-resistant state"},{"title3":"Plasma fgf21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?"},{"title3":"Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes"},{"title3":"Adiposity is a key correlate of circulating fibroblast growth factor-21 levels in African males with or without type 2 diabetes mellitus"},{"title3":"Mediterranean tomato-based sofrito sauce improves fibroblast growth factor 21 (fgf21) signaling in white adipose tissue of obese zucker rats"},{"title3":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse"},{"title3":"Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states"},{"title3":"Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy"},{"title3":"Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of fgf21 secretion"},{"title3":"Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity"},{"title3":"Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity"},{"title3":"Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes"},{"title3":"Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity"},{"title3":"Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance"},{"title3":"Clinical implications of ucp1 mRNA expression in human cervical adipose tissue under physiological conditions"},{"title3":"Functional thermogenic beige adipogenesis is inducible in human neck fat"},{"title3":"Thermogenic capacity of human periaortic adipose tissue is transformed by body weight"},{"title3":"Functional characterization of preadipocytes derived from human periaortic adipose tissue"},{"title3":"Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels"},{"title3":"Fibroblast growth factor 21 and its novel association with oxidative stress"},{"title3":"Thermogenic activation induces fgf21 expression and release in brown adipose tissue"},{"title3":"Dynamics of fat cell turnover in humans"},{"title3":"Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen?"},{"title3":"The adipochaser mouse: a model tracking adipogenesis in vivo"},{"title3":"Tracking adipogenesis during white adipose tissue development, expansion and regeneration"},{"title3":"Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance"},{"title3":"Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity"},{"title3":"'Metabolically healthy obesity': origins and implications"},{"title3":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications"},{"title3":"Metabolically healthy and unhealthy obese-the 2013 stock conference report"},{"title3":"Metabolically healthy obesity: facts and fantasies"},{"title3":"Characterising metabolically healthy obesity in weight-discordant monozygotic twins"},{"title3":"The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used"},{"title3":"The metabolically healthy but obese individual presents a favorable inflammation profile"},{"title3":"The distinction of metabolically 'healthy' from 'unhealthy' obese individuals"},{"title3":"Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the framingham heart study"},{"title3":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk"},{"title3":"Metabolically healthy but obese, a matter of time? Findings from the prospective pizarra study"},{"title3":"Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the attica cohort study"},{"title3":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women"},{"title3":"Diabetes risk among overweight and obese metabolically healthy young adults"},{"title3":"The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity"},{"title3":"Do worse baseline risk factors explain the association of healthy obesity with increased mortality risk? Whitehall II study"},{"title3":"Weight loss effect on inflammation and ldl oxidation in metabolically healthy but obese (mho) individuals: low inflammation and ldl oxidation in mho women"},{"title3":"Metabolically healthy but obese women: effect of an energy-restricted diet"},{"title3":"Effects of a lifestyle intervention in metabolically benign and malign obesity"},{"title3":"Are metabolically healthy obese individuals really healthy?"},{"title3":"Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?"},{"title3":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome"},{"title3":"The Metabolically-Obese, Normal-weight individual"},{"title3":"Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (nisei) men"},{"title3":"Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model"},{"title3":"Biology of upper-body and lower-body adipose tissue-link to whole-body phenotypes"},{"title3":"Influence of body fat content and distribution on variation in metabolic risk"},{"title3":"Body composition determines direct ffa storage pattern in overweight women"},{"title3":"Role of body fat distribution and the metabolic complications of obesity"},{"title3":"Circulating osteonectin and adipokine profiles in relation to metabolically healthy obesity in Chinese children: findings from bcams"},{"title3":"Insulin-sensitive obesity"},{"title3":"Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome"},{"title3":"Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes"},{"title3":"Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals"},{"title3":"The Obese insulin-sensitive adolescent: importance of adiponectin and lipid partitioning"},{"title3":"Metabolic obesity, adipocytokines, and inflammatory markers in asian indians-cures-124"},{"title3":"Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (mho) phenotype in African Americans"},{"title3":"Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size"},{"title3":"Adipose tissue dysfunction in nascent metabolic syndrome"},{"title3":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance"},{"title3":"Obesity is associated with macrophage accumulation in adipose tissue"},{"title3":"Adipocyte-derived serum amyloid a3 and hyaluronan play a role in monocyte recruitment and adhesion"},{"title3":"Local proliferation of macrophages in adipose tissue during obesity-induced inflammation"},{"title3":"Remodeling phenotype of human subcutaneous adipose tissue macrophages"},{"title3":"Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity"},{"title3":"Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese ldl receptor-deficient mice"},{"title3":"Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice"},{"title3":"Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity"},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization"},{"title3":"Pro-inflammatory cd11c+cd206+ adipose tissue macrophages are associated with insulin resistance in human obesity"},{"title3":"Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity"},{"title3":"Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states"},{"title3":"Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages"},{"title3":"Normalization of obesity-associated insulin resistance through immunotherapy"},{"title3":"Depot-specific differences in inflammatory mediators and a role for nk cells and ifn-gamma in inflammation in human adipose tissue"},{"title3":"Interferon-gamma, a th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity"},{"title3":"The biology of nkt cells"},{"title3":"Raising the nkt cell family"},{"title3":"Toward an understanding of nkt cell biology: progress and paradoxes"},{"title3":"Activation of natural killer t cells promotes m2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (il-4)/stat6 protein signaling axis in obesity"},{"title3":"Adipose tissue invariant nkt cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production"},{"title3":"Invariant nkt cells and cd1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity"},{"title3":"Natural killer t cells in adipose tissue prevent insulin resistance"},{"title3":"B cells promote insulin resistance through modulation of t cells and production of pathogenic igg antibodies"},{"title3":"Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice"},{"title3":"Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance"},{"title3":"Dendritic cells and adipose tissue"},{"title3":"C-reactive protein, inflammation, and innate immunity"},{"title3":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?"},{"title3":"Il-6 pathway in the liver: from physiopathology to therapy"},{"title3":"Elevated c-reactive protein levels in overweight and obese adults"},{"title3":"Acute-phase serum amyloid a: an inflammatory adipokine and potential link between obesity and its metabolic complications"},{"title3":"Relationships of serum high-sensitivity c-reactive protein and body size with insulin resistance in a japanese cohort"},{"title3":"Metabolic syndrome, insulin resistance and the inflammation markers c-reactive protein and ferritin"},{"title3":"The impact of c reactive protein on global cardiovascular risk on patients with coronary artery disease"},{"title3":"Serum amyloid a is a growth factor for 3t3-l1 adipocytes, inhibits differentiation and promotes insulin resistance"},{"title3":"Serum amyloid a as a predictor of coronary artery disease and cardiovascular outcome in women: The national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation (wise)"},{"title3":"Serum amyloid a as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis"},{"title3":"Serum amyloid a and atherosclerosis"},{"title3":"Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice"},{"title3":"Expression of apolipoprotein serum amyloid a mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid a function"},{"title3":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss"},{"title3":"Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes"},{"title3":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo"},{"title3":"Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation"},{"title3":"Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity"},{"title3":"Pgrn is a key adipokine mediating high fat diet-induced insulin resistance and obesity through il-6 in adipose tissue"},{"title3":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid"},{"title3":"Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of niddm"},{"title3":"A stress signaling pathway in adipose tissue regulates hepatic insulin resistance"},{"title3":"Interleukin-6 (Il-6) induces insulin resistance in 3t3-l1 adipocytes and is, like il-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects"},{"title3":"Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action"},{"title3":"Il-6 regulates m2 polarization and local proliferation of adipose tissue macrophages in obesity"},{"title3":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance"},{"title3":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance"},{"title3":"Serum concentrations of tnf-alpha and soluble tnf-alpha receptors in obesity"},{"title3":"Metabolic effects associated with adipose tissue distribution"},{"title3":"A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of irs-1 and irs-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation"},{"title3":"Obesity-induced inflammatory changes in adipose tissue"},{"title3":"Ccr2 modulates inflammatory and metabolic effects of high-fat feeding"},{"title3":"Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects"},{"title3":"Mcp-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity"},{"title3":"Monocyte chemoattractant protein 1 in obesity and insulin resistance"},{"title3":"Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (at): implication of macrophages resident in the at"},{"title3":"Serum amyloid a: production by human white adipocyte and regulation by obesity and nutrition"},{"title3":"Serum amyloid a: a marker of adiposity-induced low-grade inflammation but not of metabolic status"},{"title3":"Serum concentrations and expressions of serum amyloid a and leptin in adipose tissue are interrelated: the genobin study"},{"title3":"Adipokines: inflammation and the pleiotropic role of white adipose tissue"},{"title3":"Increased serum amyloid a concentrations in morbid obesity decrease after gastric bypass"},{"title3":"Deletion of serum amyloid a3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice"},{"title3":"A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid a"},{"title3":"The cell biology of fat expansion"},{"title3":"Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1h nmr spectroscopy study"},{"title3":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome"},{"title3":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (irs-1)-associated phosphatidylinositol 3-kinase activity in muscle"},{"title3":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase c, and ikappab-alpha"},{"title3":"1,2-diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo"},{"title3":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance"},{"title3":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity"},{"title3":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects"},{"title3":"Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction"},{"title3":"Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance"},{"title3":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease"},{"title3":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes"},{"title3":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of akt/protein kinase b"},{"title3":"Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling"},{"title3":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis"},{"title3":"Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism"},{"title3":"Adiponectin signaling and function in insulin target tissues"},{"title3":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating amp-activated protein kinase"},{"title3":"Chronic tnfalpha and camp pre-treatment of human adipocytes alter hsl, atgl and perilipin to regulate basal and stimulated lipolysis"},{"title3":"Nf-kappab is important for tnf-alpha-induced lipolysis in human adipocytes"},{"title3":"Neutrophil-kupffer cell interaction: a critical component of host defenses to systemic bacterial infections"},{"title3":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view"},{"title3":"Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages"},{"title3":"Inflammation and insulin resistance"},{"title3":"Liver innate immune cells and insulin resistance: the multiple facets of kupffer cells"},{"title3":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production"},{"title3":"Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue"},{"title3":"Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans"},{"title3":"Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players"},{"title3":"Intermuscular fat: a review of the consequences and causes"},{"title3":"Intermuscular adipose tissue content and intramyocellular lipid fatty acid saturation are associated with glucose homeostasis in middle-aged and older adults"},{"title3":"Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus"},{"title3":"Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding"},{"title3":"Role of muscle in triglyceride metabolism"},{"title3":"Association of abdominal muscle composition with prediabetes and diabetes: the cardia study"},{"title3":"Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction"},{"title3":"Intermuscular adipose tissue and subclinical coronary artery calcification in midlife: the cardia study (coronary artery risk development in young adults)"},{"title3":"Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk"},{"title3":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases"},{"title3":"Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes"},{"title3":"Epicardial fat thickness in non-obese neurologically impaired children: association with unfavorable cardiometabolic risk profile"},{"title3":"The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis"},{"title3":"Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes"},{"title3":"Cardiac energy metabolism in obesity"},{"title3":"Myocardial, perivascular, and epicardial fat"},{"title3":"Perivascular adipose tissue inflammation in vascular disease"},{"title3":"Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation"},{"title3":"Restoration of perivascular adipose tissue function in diet-induced obese mice without changing bodyweight"},{"title3":"Perivascular adipose tissue as a relevant fat depot for cardiovascular risk in obesity"},{"title3":"Periadventitial adipose tissue plays a critical role in vascular remodeling"},{"title3":"Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location"},{"title3":"Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels"},{"title3":"The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis"},{"title3":"Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study"},{"title3":"Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes"},{"title3":"Fatty pancreas, insulin resistance, and beta-cell function: a population study using fat-water magnetic resonance imaging"},{"title3":"Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a chinese population"},{"title3":"Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition"},{"title3":"Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity"},{"title3":"Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections"},{"title3":"Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans"},{"title3":"Brown adipose tissue activation is inversely related to central obesity and metabolic parameters in adult human"},{"title3":"Correlation of brown adipose tissue with other body fat compartments and patient characteristics: a retrospective analysis in a large patient cohort using pet/ct"},{"title3":"High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity"},{"title3":"Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans"},{"title3":"Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus"},{"title3":"Short-term cold acclimation recruits brown adipose tissue in obese humans"},{"title3":"Inflammation of brown/beige adipose tissues in obesity and metabolic disease"},{"title3":"Glucose utilization in vivo and insulin-sensitivity of rat brown adipose tissue in various physiological and pathological conditions"},{"title3":"Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans"},{"title3":"New powers of brown fat: fighting the metabolic syndrome"},{"title3":"Human brown adipose tissue: underestimated target in metabolic disease?"},{"title3":"Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans"},{"title3":"Metabolic regulation and the anti-obesity perspectives of human brown fat"},{"title3":"Macrophage infiltration into obese adipose tissues suppresses the induction of ucp1 level in mice"},{"title3":"Diet-induced obesity causes insulin resistance in mouse brown adipose tissue"},{"title3":"Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration"},{"title3":"Thermogenesis, fatty acid synthesis with oxidation, and inflammation in the brown adipose tissue of ob/ob (-/-) mice"},{"title3":"The protein kinase ikkepsilon regulates energy balance in obese mice"},{"title3":"Irf3 promotes adipose inflammation and insulin resistance and represses browning"},{"title3":"Human white and brite adipogenesis is supported by msca1 and is impaired by immune cells"},{"title3":"Mechanisms linking obesity to insulin resistance and type 2 diabetes"},{"title3":"Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus"},{"title3":"Body fat distribution and insulin resistance in healthy asian indians and caucasians"},{"title3":"Dual energy x-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome"},{"title3":"Relationship between body fat mass and free fatty acid kinetics in men and women"},{"title3":"Plasma free fatty acid turnover rate in obesity"},{"title3":"Influence of body fat distribution on free fatty acid metabolism in obesity"},{"title3":"Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with niddm"},{"title3":"Insulin action and non-esterified fatty acids. The European group for the study of insulin resistance (egir)"},{"title3":"Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals"},{"title3":"Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans"},{"title3":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity"},{"title3":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity"},{"title3":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients"},{"title3":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia"},{"title3":"Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in caucasians"},{"title3":"Metabolic fibroblast growth factors (fgfs): mediators of energy homeostasis"},{"title3":"Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat"},{"title3":"Lack of overt fgf21 resistance in two mouse models of obesity and insulin resistance"},{"title3":"Fgf-21 as a novel metabolic regulator"},{"title3":"Defining Fgf21 resistance during obesity: controversy, criteria and unresolved questions"},{"title3":"Insulin resistance and impaired adipogenesis"},{"title3":"Adipogenesis and metabolic health"},{"title3":"Adipocyte extracellular matrix composition, dynamics and role in obesity"},{"title3":"Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids"},{"title3":"Metabolic dysregulation and adipose tissue fibrosis: role of collagen vi"},{"title3":"Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance"},{"title3":"Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy"},{"title3":"Versican and the control of inflammation"},{"title3":"Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction"},{"title3":"Physiologic basis for the control of body fat distribution in humans"},{"title3":"Relationship between regional fat distribution and insulin resistance"},{"title3":"Ethnic differences in visceral adipose tissue and type 2 diabetes: filipino, African-American, and white women"},{"title3":"Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome"},{"title3":"Are there still healthy obese patients?"},{"title3":"The missing risk: mri and mrs phenotyping of abdominal adiposity and ectopic fat"},{"title3":"Associations of different adipose tissue depots with insulin resistance: a systematic review and meta-analysis of observational studies"},{"title3":"Visceral adiposity syndrome"},{"title3":"Gluteofemoral body fat as a determinant of metabolic health"},{"title3":"Mechanisms and metabolic implications of regional differences among fat depots"},{"title3":"Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity"},{"title3":"Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease"},{"title3":"Beneficial effects of subcutaneous fat transplantation on metabolism"},{"title3":"Brown adipose tissue transplantation improves whole-body energy metabolism"},{"title3":"Brown adipose tissue regulates glucose homeostasis and insulin sensitivity"},{"title3":"Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transbatation)"},{"title3":"Uptake of glucose and release of fatty acids and glycerol by rat brown adipose tissue in vivo"},{"title3":"Brown fat fuel use and regulation of energy homeostasis"},{"title3":"A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans"},{"title3":"Different metabolic responses of human brown adipose tissue to activation by cold and insulin"},{"title3":"Beta3-adrenergic receptors stimulate glucose uptake in brown adipocytes by two mechanisms independently of glucose transporter 4 translocation"},{"title3":"Browning of white adipose tissue uncouples glucose uptake from insulin signaling"},{"title3":"Glucose uptake in brown fat cells is dependent on mtor complex 2-promoted glut1 translocation"},{"title3":"Regulation of glucose homoeostasis by brown adipose tissue"},{"title3":"Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes"},{"title3":"Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans"},{"title3":"American heart association call to action: obesity as a major risk factor for coronary heart disease. Aha nutrition committee"},{"title3":"Metabolically healthy obesity: the low-hanging fruit in obesity treatment?"},{"title3":"Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis"},{"title3":"Obesity and the obesity paradox in heart failure"},{"title3":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss"},{"title3":"Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease"},{"title3":"Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition"},{"title3":"Relationship of metabolic risk factors and development of cardiovascular disease and diabetes"},{"title3":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity"},{"title3":"A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of niddm"},{"title3":"Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects"},{"title3":"Cardiovascular risk of adipokines: a review"},{"title3":"The metabolic syndrome and adipocytokines"},{"title3":"Adiponectin actions in the cardiovascular system"},{"title3":"Adiponectin reduces plasma triglyceride by increasing vldl triglyceride catabolism"},{"title3":"Adipokines, inflammation, and the endothelium in diabetes"},{"title3":"Fat, keeping the heart healthy?"},{"title3":"Adiponectin stimulates production of nitric oxide in vascular endothelial cells"},{"title3":"Adiponectin at physiologically relevant concentrations enhances the vasorelaxative effect of acetylcholine via cav-1/adipor-1 signaling"},{"title3":"Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance"},{"title3":"Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort"},{"title3":"Leptin is associated with increased risk of myocardial infarction"},{"title3":"Plasma leptin and the risk of cardiovascular disease in the west of scotland coronary prevention study (woscops)"},{"title3":"Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure"},{"title3":"Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men"},{"title3":"An inflammatory cascade leading to hyperresistinemia in humans"},{"title3":"Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction"},{"title3":"Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways"},{"title3":"Resistin is an inflammatory marker of atherosclerosis in humans"},{"title3":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin"},{"title3":"The role of cytokines in the development of atherosclerosis"},{"title3":"Cytokine-induced alteration of platelet and hemostatic function"},{"title3":"Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo"},{"title3":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women"},{"title3":"The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the fenofibrate intervention and event lowering in diabetes study"},{"title3":"Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: the multi-ethnic study of atherosclerosis"},{"title3":"Fibroblast growth factors in cardiovascular disease: the emerging role of fgf21"},{"title3":"Serum levels of fgf-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile"},{"title3":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease"},{"title3":"Relationship between 12 adipocytokines and distinct components of the metabolic syndrome"},{"title3":"Serum fgf21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status"},{"title3":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21"},{"title3":"The effects of ly2405319, an fgf21 analog, in obese human subjects with type 2 diabetes"},{"title3":"Adipose tissue, inflammation, and cardiovascular disease"},{"title3":"Does quantifying epicardial and intrathoracic fat with noncontrast computed tomography improve risk stratification beyond calcium scoring alone?"},{"title3":"Epicardial adipose tissue and insulin resistance in obese subjects"},{"title3":"Do cardiac and perivascular adipose tissue play a role in atherosclerosis?"},{"title3":"Coronary perivascular adipose tissue characteristics are related to atherosclerotic plaque size and composition. A post-mortem study"},{"title3":"Periaortic fat deposition is associated with peripheral arterial disease: the framingham heart study"},{"title3":"Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk"},{"title3":"Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study"},{"title3":"Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?"},{"title3":"Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography"},{"title3":"Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis"},{"title3":"Links between ectopic fat and vascular disease in humans"},{"title3":"Perivascular adipose tissue as a cause of atherosclerosis"},{"title3":"Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease"},{"title3":"Effect of high free fatty acids on the anti-contractile response of perivascular adipose tissue in rat aorta"},{"title3":"Human epicardial fat: what is new and what is missing?"},{"title3":"Is the amount of coronary perivascular fat related to atherosclerosis?"},{"title3":"Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese c57bl/6 mice"},{"title3":"Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis"},{"title3":"Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis"},{"title3":"Mechanisms of perivascular adipose tissue dysfunction in obesity"},{"title3":"Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development"},{"title3":"Rictor/mtorc2 loss in the myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease"},{"title3":"The science of obesity management: an endocrine society scientific statement"},{"title3":"Effects of different weight loss approaches on cvd risk"},{"title3":"A review and meta-analysis of the effect of weight loss on all-cause mortality risk"},{"title3":"Effects of diet- and exercise-induced weight loss on visceral adipose tissue in men and women"},{"title3":"Effect of diet with or without exercise on abdominal fat in postmenopausal women - a randomised trial"},{"title3":"Exercise training and/or diet on reduction of intra-abdominal adipose tissue and risk factors for cardiovascular disease"},{"title3":"Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial"},{"title3":"Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss"},{"title3":"Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women"},{"title3":"Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women"},{"title3":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the look ahead randomised clinical trial"},{"title3":"Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the look ahead trial"},{"title3":"Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look ahead trial"},{"title3":"Lack of relationship between changes in adiposity and plasma lipids following endurance training"},{"title3":"The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects"},{"title3":"Fat metabolism during low-intensity exercise in endurance-trained and untrained men"},{"title3":"Effects of exercise training on subcutaneous and visceral adipose tissue in normal- and high-fat diet-fed rats"},{"title3":"Exercise in weight management of obesity"},{"title3":"Fat distribution in men of different waist girth, fitness level and exercise habit"},{"title3":"Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes"},{"title3":"Exercise and risk factors associated with metabolic syndrome in older adults"},{"title3":"Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight"},{"title3":"Exercise training induces depot-specific adaptations to white and brown adipose tissue"},{"title3":"The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue"},{"title3":"Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in osborne-mendel rats"},{"title3":"Fat as an endocrine organ: influence of exercise"},{"title3":"Concurrent reductions of serum leptin and lipids during weight loss in obese men with type ii diabetes"},{"title3":"Changes in serum leptin concentrations in overweight japanese men after exercise"},{"title3":"Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women"},{"title3":"Adiponectin is not altered with exercise training despite enhanced insulin action"},{"title3":"Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men"},{"title3":"Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat"},{"title3":"Effect of exercise on circulating adipokine levels in obese young women"},{"title3":"Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related"},{"title3":"Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training"},{"title3":"Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study"},{"title3":"Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects"},{"title3":"Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin"},{"title3":"Exercise, adipokines and pediatric obesity: a meta-analysis of randomized controlled trials"},{"title3":"Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-a levels and arterial stiffness in obese women"},{"title3":"Exercise ameliorates the fgf21-adiponectin axis impairment in diet-induced obese mice"},{"title3":"A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis"},{"title3":"Exercise and adrenaline increase pgc-1{alpha} mRNA expression in rat adipose tissue"},{"title3":"Exercise training induces mitochondrial biogenesis and glucose uptake in subcutaneous adipose tissue through enos-dependent mechanisms"},{"title3":"Exercise as a new physiological stimulus for brown adipose tissue activity"},{"title3":"Exercise training-induced effects on the abdominal subcutaneous adipose tissue phenotype in humans with obesity"},{"title3":"Low brown adipose tissue activity in endurance-trained compared with lean sedentary men"},{"title3":"Exercise induces white adipose tissue browning across the weight spectrum in humans"},{"title3":"Effects of exercise on brown and beige adipocytes"},{"title3":"Obesity and inflammation: the effects of weight loss"},{"title3":"The effect of weight loss on c-reactive protein: a systematic review"},{"title3":"Energy restriction and weight loss on very-low-fat diets reduce c-reactive protein concentrations in obese, healthy women"},{"title3":"Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study"},{"title3":"Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification"},{"title3":"Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms"},{"title3":"Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women"},{"title3":"Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?"},{"title3":"Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery"},{"title3":"Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression"},{"title3":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss"},{"title3":"Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients"},{"title3":"The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans"},{"title3":"Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation"},{"title3":"Comparison of early (2 days) and later (28 days) response of adipose tissue to very low-calorie diet in obese women"},{"title3":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity"},{"title3":"Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling"},{"title3":"Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis"},{"title3":"Molecular mechanism of action of metformin: old or new insights?"},{"title3":"The mechanisms of action of metformin"},{"title3":"Metformin: mechanisms in human obesity and weight loss"},{"title3":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus"},{"title3":"Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin"},{"title3":"Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial"},{"title3":"Central administration of metformin into the third ventricle of c57bl/6 mice decreases meal size and number and activates hypothalamic s6 kinase"},{"title3":"Metformin and parameters of physical health"},{"title3":"Metformin in noninsulin-dependent diabetes mellitus"},{"title3":"Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats"},{"title3":"Metformin lowers plasma triglycerides by promoting vldl-triglyceride clearance by brown adipose tissue in mice"},{"title3":"Adipose tissue-derived omentin-1 function and regulation"},{"title3":"Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein a5 as part of the ampk/lxralpha signaling pathway"},{"title3":"Metformin attenuates triglyceride accumulation in hepg2 cells through decreasing stearyl-coenzyme a desaturase 1 expression"},{"title3":"Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients"},{"title3":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes"},{"title3":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus"},{"title3":"Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota"},{"title3":"Metformin and inflammation: its potential beyond glucose-lowering effect"},{"title3":"Metformin inhibits nuclear factor kappab activation and decreases serum high-sensitivity c-reactive protein level in experimental atherogenesis of rabbits"},{"title3":"Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation"},{"title3":"Metformin inhibition of glycation processes"},{"title3":"The hypothalamic glucagon-like peptide 1 receptor is sufficient but not necessary for the regulation of energy balance and glucose homeostasis in mice"},{"title3":"Lateral hypothalamic glp-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight"},{"title3":"Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes"},{"title3":"Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the lead-2 study"},{"title3":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the lead (liraglutide effect and action in diabetes)-2 study"},{"title3":"Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue"},{"title3":"Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese japanese patients with type 2 diabetes"},{"title3":"Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure"},{"title3":"Exendin-4, a glp-1 receptor agonist, directly induces adiponectin expression through protein kinase a pathway and prevents inflammatory adipokine expression"},{"title3":"Role of adipose tissue glp-1r expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes"},{"title3":"Liraglutide and cardiovascular outcomes in type 2 diabetes"},{"title3":"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins"},{"title3":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4"},{"title3":"A glp-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an apoe-/- mouse model"},{"title3":"Liraglutide causes large and rapid epicardial fat reduction"},{"title3":"Probing sglt2 as a therapeutic target for diabetes: basic physiology and consequences"},{"title3":"Canagliflozin and cardiovascular and renal events in type 2 diabetes"},{"title3":"Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes"},{"title3":"Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension"},{"title3":"Effects of sglt2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice"},{"title3":"The selective sglt2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice"},{"title3":"Treatment with the sglt2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus"},{"title3":"Sglt2 inhibition reprograms systemic metabolism via fgf21-dependent and -independent mechanisms"},{"title3":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (e-lift trial)"},{"title3":"Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial"},{"title3":"Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: A 24-week, randomized, placebo-controlled trial"},{"title3":"Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes"},{"title3":"Sglt2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing m2 macrophages in diet-induced obese mice"},{"title3":"Tofogliflozin improves insulin resistance in skeletal muscle and accelerates lipolysis in adipose tissue in male mice"},{"title3":"Bariatric surgery worldwide 2013"},{"title3":"Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery"},{"title3":"Baseline abdominal lipid partitioning is associated with the metabolic response to bariatric surgery"},{"title3":"Metabolic score: insights on the development and prediction of remission of metabolic syndrome after gastric bypass"},{"title3":"Continued loss in visceral and intermuscular adipose tissue in weight-stable women following bariatric surgery"},{"title3":"Changes in the abdominal fat distribution after gastrectomy: computed tomography assessment"},{"title3":"Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: a prospective 2-year follow up"},{"title3":"Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression"},{"title3":"Ectopic fat storage in the pancreas using 1h-mrs: importance of diabetic status and modulation with bariatric surgery-induced weight loss"},{"title3":"Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects"},{"title3":"Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss"},{"title3":"Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery"},{"title3":"Clinical and adipocytokine changes after bariatric surgery in morbidly obese women"},{"title3":"Effect of bariatric surgery on systemic and adipose tissue inflammation"},{"title3":"Serial changes in inflammatory biomarkers after roux-en-y gastric bypass surgery"},{"title3":"Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity"},{"title3":"Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation"},{"title3":"A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy"},{"title3":"Crp reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects"},{"title3":"Impact of laparoscopic roux-en-y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women"},{"title3":"Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic roux-en-y gastric bypass"},{"title3":"Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after roux-en-y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus"},{"title3":"The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes"},{"title3":"Human adipose tissue macrophages: M1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss"},{"title3":"Only c-reactive protein, but not tnf-alpha or il6, reflects the improvement in inflammation after bariatric surgery"},{"title3":"Calorie restriction and roux-en-y gastric bypass have opposing effects on circulating fgf21 in morbidly obese subjects"},{"title3":"Alterations of hormonally active fibroblast growth factors after roux-en-y gastric bypass surgery"},{"title3":"Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease"},{"title3":"Fgf19 and fgf21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss"},{"title3":"Laparoscopic sleeve gastrectomy differentially affects serum concentrations of fgf-19 and fgf-21 in morbidly obese subjects"},{"title3":"Circulating fibroblast growth factors as metabolic regulators-a critical appraisal"},{"title3":"The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis"},{"title3":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications"},{"title3":"Review of the key results from the Swedish obese subjects (sos) trial - a prospective controlled intervention study of bariatric surgery"},{"title3":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery"},{"title3":"Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence"},{"title3":"Thiazolidinediones: a new class of antidiabetic drugs"},{"title3":"Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights"},{"title3":"Effect of thiazolidinediones on body weight in patients with diabetes mellitus"},{"title3":"Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation"},{"title3":"Weight changes following the initiation of new anti-hyperglycaemic therapies"},{"title3":"Recent findings concerning thiazolidinediones in the treatment of diabetes"},{"title3":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein"},{"title3":"Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues"},{"title3":"Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients"},{"title3":"Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors"},{"title3":"The effects of adiponectin on interleukin-6 and mcp-1 secretion in lipopolysaccharide-treated 3t3-l1 adipocytes: role of the nf-kappab pathway"},{"title3":"Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3t3-l1 adipocytes"},{"title3":"Influences of ionomycin, dibutyryl-cycloamp and tumour necrosis factor-alpha on intracellular amount and secretion of apm1 in differentiating primary human preadipocytes"},{"title3":"A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia"},{"title3":"Thiazolidinediones and cardiovascular risk - a question of balance"},{"title3":"Thiazolidinediones and blood lipids in type 2 diabetes"},{"title3":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the proactive study (prospective pioglitazone clinical trial in macrovascular events): a randomised controlled trial"},{"title3":"Antiinflammatory therapy with canakinumab for atherosclerotic disease"},{"title3":"Efficacy and safety of low-dose colchicine after myocardial infarction"},{"title3":"Anti-inflammatory and immunomodulatory effects of statins"},{"title3":"Immune modulatory effects of statins"},{"title3":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive c-reactive protein levels"},{"title3":"Antiinflammatory and immunomodulatory properties of statins"},{"title3":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins"},{"title3":"Efficacy and safety of more intensive lowering of ldl cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials"},{"title3":"Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation"},{"title3":"Myeloid hmg-coa (3-hydroxy-3-methylglutaryl-coenzyme a) reductase determines adipose tissue inflammation, insulin resistance and hepatic steatosis in diet-induced obese mice"},{"title3":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome"},{"title3":"Microbial ecology: human gut microbes associated with obesity"},{"title3":"Metabolic role of lactobacilli in weight modification in humans and animals"},{"title3":"Molecular analysis of gut microbiota in obesity among indian individuals"},{"title3":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention"},{"title3":"You lose some, you win some: weight loss induces microbiota and metabolite shifts"},{"title3":"Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption"},{"title3":"The gut microbiota as an environmental factor that regulates fat storage"},{"title3":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice"},{"title3":"An obesity-associated gut microbiome with increased capacity for energy harvest"},{"title3":"Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity"},{"title3":"Bridging the gap between gut microbial dysbiosis and cardiovascular diseases"},{"title3":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice"},{"title3":"Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia"},{"title3":"Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation"},{"title3":"Metabolic endotoxemia initiates obesity and insulin resistance"},{"title3":"Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation"},{"title3":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis"},{"title3":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in nafld"},{"title3":"Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice"},{"title3":"Human oral, gut, and plaque microbiota in patients with atherosclerosis"},{"title3":"Bile acids and the gut microbiome"},{"title3":"Bile acid receptors as targets for drug development"},{"title3":"Importance of gut microbiota in obesity"},{"title3":"The enzymes, regulation, and genetics of bile acid synthesis"},{"title3":"Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults"},{"title3":"The tgr5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate"},{"title3":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation"},{"title3":"The farnesoid x receptor modulates adiposity and peripheral insulin sensitivity in mice"},{"title3":"Does bariatric surgery improve adipose tissue function?"},{"title3":"Expression and function of the bile acid receptor tgr5 in kupffer cells"},{"title3":"Gpbar1/tgr5 mediates bile acid-induced cytokine expression in murine kupffer cells"},{"title3":"Farnesoid x receptor antagonizes nuclear factor kappab in hepatic inflammatory response"},{"title3":"Long-term effects of roux-en-y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: a cross-sectional pilot study"},{"title3":"Bile acid signaling: mechanism for bariatric surgery, cure for nash?"},{"title3":"Early increases in bile acids post roux-en-y gastric bypass are driven by insulin-sensitizing, secondary bile acids"},{"title3":"Fxr is a molecular target for the effects of vertical sleeve gastrectomy"},{"title3":"The farnesoid x receptor promotes adipocyte differentiation and regulates adipose cell function in vivo"},{"title3":"The farnesoid x receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the wnt/beta-catenin pathways"},{"title3":"A metagenome-wide association study of gut microbiota in type 2 diabetes"},{"title3":"Gut microbiota and immune crosstalk in metabolic disease"},{"title3":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes"},{"title3":"High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma a-fabp and cholesterol: a pilot study of high fat diet and its intervention with lactobacillus rhamnosus gg (lgg) or telmisartan in apoe-/- mice"},{"title3":"Butyrate improves insulin sensitivity and increases energy expenditure in mice"},{"title3":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor gpr43"},{"title3":"The gut microbiome and its role in cardiovascular diseases"},{"title3":"The scfa receptor gpr43 and energy metabolism"},{"title3":"Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils"},{"title3":"Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice"},{"title3":"Gut microbiota-derived short-chain fatty acids, t cells, and inflammation"},{"title3":"Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells"},{"title3":"Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women"},{"title3":"Effect of fermented milk (yogurt) containing lactobacillus acidophilus l1 on serum cholesterol in hypercholesterolemic humans"},{"title3":"Gut dysbiosis and adaptive immune response in diet-induced obesity vs. Systemic inflammation"},{"title3":"Minireview: gut microbiota: the neglected endocrine organ"},{"title3":"The interplay between the innate immune system and the microbiota"},{"title3":"The role of the adaptive immune system in regulation of gut microbiota"},{"title3":"The microbiota in adaptive immune homeostasis and disease"},{"title3":"Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages"},{"title3":"Sodium butyrate alleviates adipocyte inflammation by inhibiting nlrp3 pathway"},{"title3":"Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women"},{"title3":"Role of toll-like receptors in pathogen recognition"},{"title3":"Fao technical meeting on prebiotics"},{"title3":"The influence of the human microbiome and probiotics on cardiovascular health"},{"title3":"Probiotics, prebiotics, synbiotics and insulin sensitivity"},{"title3":"Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial"},{"title3":"Microbial regulation of glucose metabolism and insulin resistance"},{"title3":"Probiotics l. Plantarum and l. Curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity"},{"title3":"Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice"},{"title3":"Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity"},{"title3":"Specific synbiotics in early life protect against diet-induced obesity in adult mice"},{"title3":"Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (angptl4)"},{"title3":"Supplementation of Lactobacillus curvatus hy7601 and Lactobacillus plantarum ky1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity"},{"title3":"Administration of lactobacillus gasseri sbt2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice"},{"title3":"Anti-obesity effect of lactobacillus gasseri sbt2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice"},{"title3":"Regulation of abdominal adiposity by probiotics (lactobacillus gasseri sbt2055) in adults with obese tendencies in a randomized controlled trial"},{"title3":"Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin"},{"title3":"Lipid-lowering nutraceuticals in clinical practice: position paper from an international lipid expert panel"}]},{"title2":"Body mass index is associated with the development of acute respiratory distress syndrome","References":[{"title3":"Obesity as a medical problem"},{"title3":"Excess deaths associated with underweight, overweight, and obesity"},{"title3":"Body mass index and outcomes in critically injured blunt trauma patients: weighing the impact"},{"title3":"Obesity in critical care"},{"title3":"Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study"},{"title3":"Outcome of morbid obesity in the intensive care unit"},{"title3":"Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury"},{"title3":"The association between body mass index and clinical outcomes in acute lung injury"},{"title3":"Effect of obesity on intensive care morbidity and mortality: a meta-analysis"},{"title3":"Incidence and outcomes of acute lung injury"},{"title3":"Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury"},{"title3":"Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion"},{"title3":"Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome"},{"title3":"Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome"},{"title3":"Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults"},{"title3":"Peri-operative risk factors for acute lung injury after elective oesophagectomy"},{"title3":"Risk factors for early primary graft dysfunction after lung transplantation: a registry study"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Risk factors for ARDS in patients receiving mechanical ventilation for &gt; 48 h"},{"title3":"Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients"},{"title3":"Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation"},{"title3":"Obesity and infection"},{"title3":"Intensive-Care Patients with Severe Novel Influenza A (H1N1) Virus Infection- Michigan, June 2009"},{"title3":"Impact of obesity in mechanically ventilated patients: a prospective study"},{"title3":"Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states"},{"title3":"Influence of obesity on sepsis"},{"title3":"Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome"},{"title3":"Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury"},{"title3":"Leptin regulates proinflammatory immune responses"},{"title3":"Leptin resistance protects mice from hyperoxia-induced acute lung injury"},{"title3":"ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin"},{"title3":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury"},{"title3":"The relationship between body mass index and postoperative mortality from critical illness"},{"title3":"Body mass index. An additional prognostic factor in ICU patients"}]},{"title2":"Socioeconomic status and obesity","References":[]},{"title2":"Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Epidemiological characteristics and incubation period of 7015 confirmed cases with coronavirus disease 2019 outside Hubei Province in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations"},{"title3":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"COVID-19 with different severity: a multi-center study of clinical features"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China"},{"title3":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools"},{"title3":"Cytokine storm intervention in the early stages of COVID-19 pneumonia"},{"title3":"Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Targeting potential drivers of COVID-19: neutrophil extracellular traps"},{"title3":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Early chronic obstructive pulmonary disease: definition, assessment, and prevention"},{"title3":"The definition of acute kidney injury and its use in practice"},{"title3":"Acute respiratory failure in immunocompromised adults"},{"title3":"Obesity could shift severe COVID-19 disease to younger ages"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"New understanding of the damage of SARS-CoV-2 infection outside the respiratory system"},{"title3":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages"},{"title3":"Inflammation resolution: a dual-pronged approach to averting cytokine storms in"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"}]},{"title2":"Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence","References":[]},{"title2":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","References":[{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP (2020) Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 10.1056/NEJMsb2005114"},{"title3":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 10.1111/jth.14820"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 10.1001/jama.2020.1585"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 10.1111/jth.14860"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy"},{"title3":"Early detection of disseminated intravascular coagulation during septic shock: a multicenter prospective study"},{"title3":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)"},{"title3":"Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation"},{"title3":"Hemostasis and thrombosis in continuous renal replacement treatment"},{"title3":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients"},{"title3":"The endothelium in hypoxic pulmonary vasoconstriction"},{"title3":"Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis"},{"title3":"The stimulation of thrombosis by hypoxia"},{"title3":"Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung"},{"title3":"Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome"},{"title3":"Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"The pathogenesis of the antiphospholipid syndrome"},{"title3":"High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening"},{"title3":"Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection"},{"title3":"Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS"},{"title3":"Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment"},{"title3":"Multiple roles of the coagulation protease cascade during virus infection"},{"title3":"Molecular pathogenesis of viral hemorrhagic fever"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Lymphocyte subset (CD4 + , CD8 +) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19","References":[{"title3":"Chen J., Qi T., Liu L., Ling Y., Qian Z., Li T., et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect"},{"title3":"National Health Commission of the People's Republic of China. Guidelines for the Diagnosis and Treatment of COVID-19 (Trial Version 6) 2020. Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm."},{"title3":"Acute primary infection with cytomegalovirus (CMV) in kidney transplant recipients results in the appearance of a phenotypically aberrant CD8(+) T cell population"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Decreased CCR5 expression on CD4(+) t cells of SIV-infected sooty mangabeys"},{"title3":"Respiratory syncytial virus and other respiratory viruses"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]}]}]}